fluorodeoxyglucose f18 has been researched along with Cancer of Cervix in 438 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (1.37) | 18.2507 |
2000's | 130 (29.68) | 29.6817 |
2010's | 238 (54.34) | 24.3611 |
2020's | 64 (14.61) | 2.80 |
Authors | Studies |
---|---|
Cheng, W; Hou, G; Jiang, Y; Li, F; Zhu, Z | 1 |
Cui, Y; Ji, Y; Shao, C; Shi, D; Su, N; Wang, Y; Zheng, J | 1 |
Gómez, EJ; Muñoz-Lopez, B; Pedraza, S; Pérez-Regadera, JF; Sánchez-González, P; Sarandeses, P; Seiffert, AP | 1 |
Li, R; Liu, Q; Liu, S; Pan, H; Song, S; Sun, D; Wang, L; Yang, H | 1 |
Brambs, CE; Combs, SE; Hugo, C; Knorr, K; Scharl, S; Schüttrumpf, L; Weidenbaecher, CB | 1 |
Bourdon, A; Duraes, M; Ferrer, C; Khebbeb, S; Rathat, G; Serrand, C | 1 |
Liu, W; Ou, X; Yao, X | 1 |
Greenwade, MM; Grigsby, PW; Massad, LS; Mckinnish, TR; Mutch, DG; Powell, MA; Schwarz, JK; Siegel, BA; Thaker, PH; Wilkinson-Ryan, I | 1 |
Chen, Z; Dong, X; Ming, Y; Wang, H; Wu, N; Zhao, J | 1 |
Creekmore, AN; Dehdashti, F; Duska, LR; Fracasso, PM; Gao, F; Goodner, SA; Lothamer, HL; Menias, CO; Rader, JS; Rehm, PK; Siegel, BA; Thaker, PH; Uliel, L; Zoberi, I | 1 |
Angeles, MA; Attal, J; Bétrian, S; Chantalat, E; Daix, M; Ducassou, A; Ferron, G; Gabiache, E; Lusque, A; Martinez, A | 1 |
Chen, X; Hua, J; Liu, L; Liu, Y; Xu, S; Zhang, W | 1 |
Gerke, O; Hildebrandt, MG; Holm, J; Jensen, PT; Jochumsen, KM; Spasojevic, D; Sponholtz, SE; Thomassen, A; Vilstrup, MH | 1 |
Artiko, V; Odalovic, S; Petrovic, J; Popovic, M; Rankovic, N; Sobic Saranovic, D; Stojiljkovic, M; Veljkovic, M | 1 |
Cho, HW; Eo, JS; Hong, JH; Kim, S; Lee, ES; Lee, JK | 1 |
Akuamoa-Boateng, D; Baues, C; Claus, K; Drzezga, A; Fischer, T; Kobe, C; Köhler, C; Linde, P; Marnitz, S; Roth, KS; Schomäcker, K; Schömig-Markiefka, B; Trommer, M; van Heek, L; Wegen, S; Weindler, J | 1 |
Dhomps, A; Tordo, J; Trecourt, A | 1 |
Bjurberg, M; Markus, M; Sartor, H; Trägårdh, E | 1 |
Brenot Rossi, I; Cancès-Lauwers, V; Chantalat, E; Chollet, C; Courbon, F; Gabiache, E; Gallo, F; Jalaguier, A; Lambaudie, E; Leguevaque, P; Martinez, A; Motton, S; Weyl, A | 1 |
Chan, KC; Lee, EYP; Perucho, JAU; Subramaniam, RM | 1 |
Abgral, R; Bourbonne, V; Classe, JM; De Cuypere, M; Dupré, PF; Gennigens, C; Hatt, M; Hermesse, J; Hustinx, R; Kridelka, F; Lovinfosse, P; Lucia, F; Mervoyer, A; Miranda, O; Pleyers, C; Pradier, O; Rousseau, C; Schick, U; Visvikis, D; Vos, W | 1 |
Röhrich, M | 1 |
Guan, C; Liu, W; Zhu, M; Zhuo, Q; Zuo, Y | 1 |
Carré, A; Chargari, C; Classe, M; Deutsch, E; Genestie, C; Guckenberger, M; Guren, MG; La Greca Saint-Esteven, A; Lemanski, C; Malinen, E; McDermott, G; McKenna, J; Niyoteka, S; Robert, C; Rouhi, R; Scarsbrook, A; Seban, RD; Sun, R; Tanadini-Lang, S | 1 |
Baruch, Y; Even-Sapir, E; Grisaru, D; Kerzhner, K; Laskov, I; Michaan, N; Peleg-Hasson, S; Rabin, T; Raz, Y; Safra, T; Wenkert, A | 1 |
Cai, L; Chen, X; Chen, Y; He, X; Liu, M; Shu, Q | 1 |
Pak, K; Yoon, HJ | 1 |
Aziz, A; Bhosale, P; Frumovitz, M; Gonzales, NR; Jhingran, A; Morani, AC; Ramalingam, P; Salvo, G; Sun, J | 1 |
Isaji, Y; Okazawa, H; Orisaka, M; Tsujikawa, T; Tsuyoshi, H; Yoshida, Y | 1 |
Chen, Z; Han, F; Sun, H; Sun, W; Wang, T | 1 |
Dehdashti, F; Grigsby, PW; Lin, AJ; Markovina, S; Mutch, DG; Powell, MA; Schwarz, J; Siegel, BA; Thaker, PH; Wright, JD | 1 |
Du, S; Gao, S; Lu, Z; Sun, H; Xin, J | 1 |
Arshad, MA; Barwick, TD; Gandy, N; Park, WE; Rockall, AG | 1 |
Bucella, D; Buxant, F; Charaf, G; Crener, K; De Cuypere, M; Duch, J; Fastrez, M; Gebhart, G; Gennigens, C; Goffin, F; Hustinx, R; Jouret, M; Kridelka, F; Lovinfosse, P; Luyckx, M; Rovira, R; Squifflet, JL | 1 |
Angeles, MA; Chantalat, E; Courbon, F; Ducassou, A; Dupuis, N; Ferron, G; Gabiache, E; Gladieff, L; Hitzel, A; Lusque, A; Martinez, A; Martinez, C; Tanguy Le Gac, Y; Voglimacci, M | 1 |
Hatazawa, J; Kato, H; Kawano, M; Kimura, T; Komura, N; Kozasa, K; Kuroda, H; Mabuchi, S; Matsumoto, Y; Sasano, T; Shimura, K; Takahashi, R; Yokoi, E | 1 |
Gurdal, N; Ozkan, A; Uysal, E; Yılmaz, BD | 1 |
Bouchard, M; Lemay, J; Rousseau, É | 1 |
Atun, R; Hricak, H; Scott, AM; Vargas, HA; Ward, ZJ; Woo, S | 1 |
Bohn, P; Damilleville-Martin, M; Decazes, P; Modzelewski, R; Thureau, S; Vera, P | 1 |
Beriwal, S; Moon, CH; Nguyen, NC | 1 |
Chevere-Mourino, CM; Eng, TY; Leath, CA; Lowenstein, J; Medina-Palomo, A; Mell, LK; Miller, A; Moore, KL; Moxley, KM; Nguyen, H; Williamson, CW; Xiao, Y; Yusufaly, T; Zaid, T | 1 |
Chapman, JS; Chen, LM; Hsu, IC; Peters, PN; Pierson, WE; Westphalen, AC | 1 |
Ackermans, LL; Beets-Tan, RG; Griethuysen, JJV; Lambregts, DM; Maas, M; Min, LA; Nowee, ME; Roberti, S; Vogel, WV | 1 |
Amant, F; De Jaeghere, EA; De Man, K; De Visschere, PJL; De Wever, O; Denys, HG; Laloo, F; Lippens, L; Makar, A; Naert, E; Tummers, P; Van Bockstal, M; Van de Vijver, K; Van Dorpe, J; Vandecasteele, K | 1 |
Ge, H; Liu, S; Pan, H; Song, S; Wang, C; Xia, L; Yang, Z; Zhou, Z | 1 |
Adam, JA; Bipat, S; Mom, CH; Stoker, J; van Diepen, PR; van Eck-Smit, BLF | 1 |
Balaji, R | 1 |
Adam, JA; Chargari, C; Delgado Bolton, RC; Kidd, E; Loft, A; Schöder, H; Veit-Haibach, P; Vogel, WV | 1 |
Aboagye, EO; Arshad, MA; Barwick, TD; Bharwani, N; Gitau, S; Park, WE; Patel, NH; Rockall, A; Tam, H | 1 |
Bae, DS; Cho, WK; Cho, YS; Choi, CH; Kim, BG; Kim, N; Kim, TJ; Lee, JW; Lee, YY; Park, W | 1 |
Jin, J; Li, X; Sun, H; Wang, X; Wu, K; Yu, Y | 1 |
Cortés-Romera, M; Mestres-Martí, J; Robles-Barba, JJ; Sabaté-Llobera, A; Soldevila-Lozano, C | 1 |
Hietanen, S; Hynninen, J; Narva, S; Rinta-Kiikka, I; Steiner, A; Virtanen, J | 1 |
Carré, A; Coutant, C; Dabakuyo, S; Kamga, AM; Rouffiac, M; Sellier, J | 1 |
Chargari, C; Deandreis, D; Genestie, C; Gouy, S; Grimaldi, S; Ilenko, A; Leary, A; Maulard, A; Morice, P; Pautier, P; Seebacher, V; Terroir, M | 1 |
Dehdashti, F; Grigsby, PW; Lin, AJ; Markovina, S; Massad, LS; Mutch, DG; Powell, MA; Schwarz, JK; Siegel, BA; Thaker, PH | 1 |
Aldemir, OS; Beyan, E; Budak, A; Budak, E; Ileri, A; Inan, AH; Kanmaz, AG; Tosun, G | 1 |
Parooie, F; Salarzaei, M; Sanei Sistani, S | 1 |
Bernard, C; Decuypere, M; Ferreira, M; Hatt, M; Hermesse, J; Hustinx, R; Kridelka, F; Lambin, P; Leijenaar, RTH; Lovinfosse, P; Lucia, F; Meyer, PE; Reinhold, C; Robin, P; Rousseau, C; Schick, U; Visvikis, D | 1 |
Adachi, S; Enomoto, T; Haino, K; Ishiguro, T; Ishii, S; Nishikawa, N; Soeda, S; Watanabe, T; Yamaguchi, M; Yoshihara, K | 1 |
Bharwani, N; Cunha, TM; Forstner, R; Gigli, S; Gui, B; Kido, A; Lakhman, Y; Manganaro, L; Nougaret, S; Rizzo, S; Rockall, A; Sala, E; Vinci, V | 1 |
Mayadev, J; Williamson, CW; Zamarin, D | 1 |
Bjørnholt, SM; Frøding, LP; Fuglsang, K; Hildebrandt, MG; Jensen, PT; Markauskas, A; Mogensen, O; Parner, E; Schledermann, D; Sponholtz, SE; Vilstrup, MH | 1 |
Cohen, D; Even-Sapir, E; Hazut Krauthammer, S; Levine, C | 1 |
Guo, Y; Li, X; Sun, H; Xu, C; Yu, Y | 1 |
Guler, OC; Onal, C; Reyhan, M; Yapar, AF | 2 |
Acosta, O; De Crevoisier, R; Der Sarkissian, H; Devillers, A; Grossiord, E; Guzman, L; Leseur, J; Ospina, JD; Roman-Jimenez, G | 1 |
Jeon, S; Lee, JW; Lee, SM; Mun, ST | 1 |
Grigsby, PW; Hagemann, AR; Ioffe, YJ; Massad, LS; Mutch, DG; Powell, MA; Schwarz, JK; Thaker, PH | 1 |
Chen, SW; Hsieh, TC; Kao, CH; Liang, JA; Shen, WC; Yen, KY | 1 |
Bremicker, K; Exner, M; Höhn, AK; Meyer, HJ; Purz, S; Schob, S; Stumpp, P; Surov, A | 1 |
Meijerink, MR; Melenhorst, MCAM; Scheffer, HJ; van den Tol, MP; van Grieken, N; Vroomen, LGPH | 1 |
Alaref, A; Lisbona, R; Reinhold, C; Sugimura, K; Tamada, T; Ueno, Y | 1 |
Hoh, CK; Li, N; Mahantshetty, U; Mell, LK; Moore, KL; Noticewala, SS; Shen, H; Sirak, I; Tarnawski, R; Williamson, CW | 1 |
Kim, JH; Kim, YM; Kim, YT; Lee, HJ; Lee, JJ; Nam, JH; Park, JY | 1 |
Buvat, I; Chargari, C; Dercle, L; Deutsch, E; Escande, A; Gouy, S; Haie-Meder, C; Limkin, E; Nioche, C; Orlhac, F; Reuzé, S; Riet, F; Robert, C | 1 |
Hwang, JP | 1 |
Bernd, K; Gasparri, ML; Genoud, S; Mueller, MD; Papadia, A | 1 |
Narayanan, P; Sahdev, A | 1 |
Aktas, B; Forsting, M; Grueneisen, J; Herrmann, K; Kirchner, J; Ruhlmann, V; Sarabhai, T; Schaarschmidt, BM; Umutlu, L; Wetter, A | 1 |
Buvat, I; Chargari, C; Dercle, L; Deutsch, E; Escande, A; Haie-Meder, C; Limkin, E; Orlhac, F; Reuze, S; Robert, C; Schernberg, A; Sun, R | 1 |
Chaddha, U; English, R; Panchabhai, TS; Patil, PD | 1 |
Chen, L; Fu, C; Li, A; Tan, Z; Xu, X | 1 |
Mahajan, S; Pandit-Taskar, N | 1 |
Chao, A; Chou, HH; Huang, YT; Lai, CH; Lin, G; Liu, FY; Su, TP; Wang, CC; Yen, TC | 1 |
Hui, ES; Lai, AYT; Lee, EYP; Perucho, JAU; Xu, X | 1 |
Desseroit, MC; Hatt, M; Lucia, F; Malhaire, JP; Miranda, O; Pradier, O; Robin, P; Schick, U; Visvikis, D | 1 |
Guler, OC; Onal, C; Torun, N; Yildirim, BA | 1 |
Ellmann, A; Morkel, M; Simonds, H; Warwick, J | 1 |
Buwenge, M; Cammelli, S; Castellucci, P; Cilla, S; Cima, S; De Iaco, P; Fanti, S; Ferioli, M; Ferrandina, G; Galuppi, A; Macchia, G; Morganti, AG; Perrone, AM; Rubino, D; Salizzoni, E | 1 |
Fujita, S; Osaka, Y; Sakamoto, J; Sasagawa, T; Shibata, T; Takagi, H | 1 |
Chang, YC; Chao, A; Chou, HH; Lai, CH; Liu, FY; Su, TP; Wang, CC; Yen, TC | 1 |
Bhosale, PR; Devine, C; Faria, S; Iyer, RB; Patnana, M; Sagebiel, T; Viswanathan, C | 1 |
Grigsby, PW; Rao, YJ | 1 |
Altoos, B; Harkenrider, MM; Small, W | 1 |
Azmi, A; Gillham, C; Keenan, LG; McArdle, O; Rock, K; Salib, O | 1 |
Bourhis, J; Castelli, J; Depeursinge, A; Herrera, FG; Ozsahin, M; Prior, JO; Scher, N | 1 |
Ohmichi, M; Sasaki, S; Tanaka, T; Terai, Y; Tsuchihashi, H; Yamada, T; Yamamoto, K | 1 |
Goense, L; Lam, MGEH; Meijer, GJ; Meziani, J; Ruurda, JP; van Hillegersberg, R; van Rossum, PSN; Wessels, FJ | 1 |
Borde, CR; Palaniswamy, SS; Subramanyam, P | 1 |
Duan, D; Jing, X; Li, H; Li, S; Pang, H; You, J | 1 |
Adam, JA; Arkies, H; Hinnen, K; Laan, JJ; Mom, CH; Stalpers, LJ; Stoker, J; van Eck-Smit, BL; van Os, R; van Waesberghe, JH | 1 |
Banks, TI; Hristov, D; Kidd, EA; von Eyben, R | 1 |
Ahn, BC; Chong, GO; Hong, CM; Jeong, JH; Jeong, SY; Lee, CH; Lee, J; Lee, SW; Lee, YH; Park, SH; Son, SH | 1 |
De Crescenzo, EM; De Iaco, P; Dondi, G; Fanti, S; Lima, GM; Matti, A; Morganti, AG; Nanni, C; Naselli, N; Perrone, AM; Vara, G | 1 |
Bonyadlou, S; Brunette, LL; Groshen, S; Ji, L; Lin, YG; Matsuo, K; Mehta, A; Roman, LD; Shuster, D; Sposto, R | 1 |
Canbaz, F; Celik, H; Kefeli, M; Tosun, M | 1 |
Du, S; Guo, Q; Sun, H; Xin, J; Xu, W; Zhang, L | 1 |
Han, S; Kim, H; Kim, YJ; Suh, CH; Woo, S | 1 |
Hong-Zan, S; Jun, X; Li-Ou, Z; Qi-Yong, G; Xiao-Xi, B; Zai-Ming, L; Zhong-Wei, C | 1 |
Kidd, EA; Koenig, JL; Kozak, MM; von Eyben, R | 1 |
Guo, Q; Li, B; Sun, H; Wang, X; Zhang, S | 1 |
Dehdashti, F; Grigsby, PW; Kidd, E; Lin, AJ; Markovina, S; Massad, LS; Mutch, DG; Mutic, S; Powell, MA; Schwarz, J; Siegel, BA; Thaker, PH | 1 |
Höhn, AK; Meyer, HJ; Purz, S; Sabri, O; Schob, S; Surov, A; Winter, K | 1 |
Alfieri, J; Bonaffini, PA; Desseroit, MC; Hatt, M; Lucia, F; Masson, I; Mervoyer, A; Miranda, O; Pradier, O; Reinhold, C; Robin, P; Schick, U; Vallières, M; Visvikis, D | 1 |
Çermik, TF; Dağ, S; Ergul, N; Yilmaz, B | 1 |
Anthes, M; Arsenault, J; D'Souza, D; Dayes, I; Dhamanaskar, K; Elit, LM; Filion, M; Fyles, AW; Gu, CS; Gulenchyn, KY; Levine, MN; Metser, U; Pond, GR; Samant, R; Thomas, G; Whelan, TJ | 1 |
Chantalat, E; Courbon, F; Ducassou, A; Ferron, G; Gabiache, E; Lusque, A; Martinez, A; Motton, S; Querleu, D; Voglimacci, M | 1 |
Dehdashti, F; Grigsby, P; Lin, A; Ma, S; Markovina, S; Powell, M; Schwarz, J; Siegel, B | 1 |
Burchardt, E; Cegla, P; Cholewinski, W; Roszak, A; Urbanski, B | 1 |
Grigsby, PW; Lin, AJ; Ma, S; Markovina, S; Mutch, DG; Powell, MA; Schwarz, J | 1 |
Guo, Q; Li, K; Sun, H | 1 |
Ankrah, AO; Janse van Rensburg, C; Lawal, IO; Lengana, T; Popoola, GO; Reyneke, F; Sathekge, MM | 1 |
Allen, PK; Bhosale, PR; Cardenas, CE; Fang, P; Frumovitz, MM; Fuller, CD; Ho, JC; Jhingran, A; Klopp, AH; Mohamed, ASR | 1 |
Amorim, BJ; Bernardo, WM; Brito, AET; Esteves, F; Gomes, G; Matushita, C | 1 |
Atri, M; Lee, SI | 1 |
Ahn, BC; Chong, GO; Hong, CM; Jeong, JH; Jeong, SY; Lee, J; Lee, SW; Lee, YH; Park, SH | 1 |
Carpenter, DJ; Chino, JP; Craciunescu, O; Jacobs, CD; Wong, TZ | 1 |
Han, S; Kim, YJ; Kim, YS; Nam, JH | 1 |
Burchardt, E; Cegla, P; Cholewinski, W; Czepczynski, R; Kubiak, A; Roszak, A | 1 |
Lin, ZG; Ouyang, L; Shi, ZY | 1 |
Choi, KU; Kim, SJ; Park, SI; Suh, DS; Yoon, MS | 1 |
Amit, A; Keidar, Z; Lavie, O; Lowenstein, L; Netzer, I; Sobeh, S; Yosef, RB | 1 |
Fukawa, T; Fukumori, T; Izaki, H; Kanayama, HO; Komori, M; Nakatsuji, H; Senzaki, T; Takahashi, M; Takemura, M; Yamaguchi, K; Yamamoto, Y | 1 |
Grigsby, PW; Mutch, DG; Powell, MA; Schwarz, JK; Zighelboim, I | 1 |
Kato, H; Kimura, T; Kishimoto, T; Mabuchi, S | 1 |
Alvarez Secord, A; Case, AS; Cohn, DE; Dehdashti, F; Eisenhauer, EL; Gao, F; Lippmann, LT; Massad, LS; Mutch, DG; Powell, MA; Rader, JS; Thaker, PH; Valea, FA; Wright, JD; Zighelboim, I | 1 |
Adams, R; Debernardo, R; Dowlati, A; Faulhaber, P; Fusco, N; Kunos, CA; Radivoyevitch, T; Redline, R; Resnick, K; Waggoner, S; Zanotti, K | 1 |
Dhull, VS; Jain, SK; Kumar, R; Maharjan, S; Malhotra, A; Patel, CD; Sharma, DN; Sharma, P; Thulkar, S | 1 |
Amrami, KK; Garcia, JJ; Howe, BM; Nathan, MA; Spinner, RJ | 1 |
Guler, OC; Onal, C; Oymak, E; Parlak, C; Reyhan, M | 1 |
Feng, Y; Mao, X; Qie, M; Zhao, Q | 1 |
Logeswaran, P; Mercier, G; Mhlanga, JC; Mirpour, S; Russo, G; Subramaniam, RM | 1 |
Chan, CY; Lee, SY; Lim, D; Lim, KH | 1 |
Schwarz, JK | 1 |
Choi, JY; Huh, SJ; Kim, BT; Lee, JE; Nam, H; Oh, D; Park, W | 1 |
Bai, L; Chen, Y; Chu, Y; Han, L; Lin, W; Wang, F; Yang, X; Zheng, A | 1 |
Bjurberg, M; Brun, E | 1 |
Cheon, GJ; Chung, HH; Kang, KW; Kim, JW; Park, NH; Song, YS | 1 |
Chung, JK; Im, HJ; Kim, JY; Kim, SK; Kim, TS; Lee, ES; Park, SY; Yoon, HJ | 1 |
Brooks, FJ; Grigsby, PW | 3 |
Hu, J; Li, JP; Li, WW; Li, X; Liu, JY; Lu, HJ; Ma, WL; Shi, M; Wang, J; Wang, N; Wang, SJ; Wei, LC; Zhang, Y; Zhou, YC | 1 |
Fan, L; Guo, F; Tian, J; Yang, R | 1 |
Dong, A; Wang, Y; Xu, M; Zhai, Z; Zuo, C | 1 |
Bal, C; Dhull, VS; Kumar, R; Maharjan, S; Patel, C; Sharma, DN; Sharma, P; Suman Kc, S | 1 |
Guo, Q; Lu, Y; Peng, W; Sun, H; Wang, B; Xin, J; Zhai, W; Zhang, S; Zhao, L | 1 |
Adachi, M; Aoki, D; Banno, K; Iida, M; Kisu, I; Masuda, K; Nakamura, K; Nogami, Y; Tanaka, K; Tominaga, E; Umene, K | 1 |
Apostolova, I; Brenner, W; Buchert, R; Derlin, T; Hofheinz, F; Köhler, C; Marnitz, S; Michel, R; Prasad, V; Rosner, C; Steffen, IG | 1 |
Guo, Q; Ma, J; Ma, Q; Sun, H; Xin, J; Zhang, S | 1 |
Aebersold, DM; Cihoric, N; Klaeser, B; Krüger, K; Lössl, K; Tapia, C | 1 |
Guo, Q; Ma, J; Ma, Q; Sun, H; Xin, J; Zhang, S; Zhao, X | 2 |
Abu-Rustum, NR; Burger, IA; Goldman, DA; Hricak, H; Kollmeier, MA; Miccò, M; Park, KJ; Sala, E; Vargas, HA | 1 |
Ding, XP; Feng, L; Ma, L | 1 |
Aktas, B; Beiderwellen, K; Buderath, P; Forsting, M; Gratz, M; Grueneisen, J; Heusch, P; Lauenstein, T; Ruhlmann, V; Umutlu, L | 1 |
Beiderwellen, K; Forsting, M; Gratz, M; Grueneisen, J; Heubner, M; Heusch, P; Kinner, S; Lauenstein, T; Ruhlmann, V; Schulze-Hagen, A; Umutlu, L | 1 |
Driscoll, DO; Halpenny, D; Johnston, C; Keogan, M; Sheehy, N | 1 |
d'Amico, A; Di Pietro, M; Gorczewska, I; Gorczewski, K; Turska-d'Amico, M | 1 |
Bochev, P; Chaushev, B; Dancheva, J; Encheva, E; Hristozov, K; Klisarova, A; Krasnaliev, I; Nenkov, R; Radev, R; Yordanov, K; Yordanova, C | 1 |
Guo, HM; Han, JK; Lu, YJ; Lv, K; Wu, ZX; Zhang, K | 1 |
Aktas, B; Beiderwellen, K; Buderath, P; Forsting, M; Grueneisen, J; Heusch, P; Kraff, O; Lauenstein, TC; Ruhlmann, V; Umutlu, L | 1 |
Dong, Y; Liu, Y; Qian, W; Wang, X; Wang, Y; Wu, S; Zhang, J | 1 |
Doudouh, A; El Hammoumi, M; El Marjany, M; Kabiri, el H; Mansouri, H; Moussaoui, D | 1 |
Aoki, D; Banno, K; Iida, M; Irie, H; Kisu, I; Masugi, Y; Murakami, K; Nogami, Y; Okuda, S; Tanaka, K; Tominaga, E | 1 |
Baek, JH; Cho, KJ; Choi, SH; Kim, JS; Kim, SY; Lee, JH; Lee, JR; Nam, SY; Roh, JL | 1 |
Chowdhury, FU; Cooper, RA; Fleming, S; Patel, CN; Scarsbrook, AF; Swift, SE; Thygesen, HH | 1 |
Bourhis, J; Callaway, S; Elicin, O; Herrera, FG; Ozsahin, M; Prior, JO | 1 |
Catalano, OA; Dehdashti, F; Lee, SI | 1 |
Cho, SH; Chung, HW; Hong, S; Kim, SN; Kim, WY; Lee, SJ; Lim, JY; So, Y | 1 |
Bristow, RE; Eskander, RN; Grove, N; Zheng, M | 1 |
Chang, TC; Chang, YC; Hong, JH; Kao, WH; Lai, CH; Lin, SY; Ng, KK; Tsai, CS | 1 |
Katano, A; Nakagawa, K; Okuma, K; Takenaka, R; Yamashita, H | 1 |
Chen, Z; Dai, R; Liang, Y; Mu, W; Shen, W; Tian, J; Wu, N; Yang, F | 2 |
Bernshaw, D; Bressel, M; Callahan, J; Deb, S; Hicks, RJ; Mileshkin, L; Narayan, K; Rischin, D; Siva, S; Young, RJ | 1 |
Arnesen, MR; Bruheim, K; Dale, E; Eilertsen, K; Helland, Å; Hellebust, TP; Knudtsen, IS; Løndalen, AM; Malinen, E; Rekstad, BL | 1 |
Liu, GC; OuYang, XL; Zhang, WJ; Zhang, XM; Zheng, LC | 1 |
De Leeuw, AA; Fokdal, LU; Gormsen, LC; Jürgenliemk-Schulz, IM; Kroon, PS; Lindegaard, JC; Ramlov, A; Tanderup, K | 1 |
Abu-Rustum, NR; Burger, IA; Goldman, DA; Gonen, M; Hricak, H; Kollmeier, MA; Micco, M; Park, KJ; Sala, E; Vargas, HA; Yakar, D | 1 |
Kim, SJ; Lee, CH; Pak, K; Yun, MS | 1 |
Cheon, GJ; Chung, HH; Chung, JK; Im, HJ; Kang, KW; Kim, EE; Lee, DS; Sarker, A | 1 |
Chang, TC; Chen, CY; Chen, MY; Chou, HH; Huang, YT; Jung, SM; Lai, CH; Lin, G; Liu, FY; Pan, YB; Tsai, JC; Wu, RC; Yang, LY; Yen, TC | 1 |
Barthel, H; Brandmaier, P; Bremicker, K; Höckel, M; Kahn, T; Kluge, R; Purz, S; Sabri, O; Stumpp, P | 1 |
Agarwal, KK; Kumar, R; Roy, SG | 1 |
Carmona, R; Hoh, CK; Karunamuni, RA; Mell, LK; Pritz, J; Wyss, JC | 1 |
Acosta, O; De Crevoisier, R; Devillers, A; Le Gouestre, J; Leseur, J; Ospina, JD; Roman-Jimenez, G; Simon, A; Terve, P | 1 |
Chen, Y; Feng, Y; Fu, S; Qin, X; Sun, X; Wu, J; Yang, B; You, H; Yu, Y; Zhang, G | 1 |
Lai, CH | 1 |
Cheon, GJ; Chung, HH; Ha, S; Kang, SY; Kim, JW; Park, NH; Song, YS | 1 |
Dhull, VS; Khangembam, BC; Kumar, R; Kumar, S; Rana, N; Shamim, SA; Sharma, D; Sharma, P; Verma, S | 1 |
Lu, P; Sun, Y; Yu, L | 1 |
Kim, CK; Park, BK; Park, JJ | 1 |
Chen, FL; Chung, YL; Horng, CF; Lee, PI | 1 |
Eo, JS; Hong, JH; Jung, US; Kim, S; Lee, JK; Min, KJ; So, KA | 1 |
Chino, Y; Kimura, H; Kurokawa, T; Okazawa, H; Rahman, T; Shinagawa, A; Tsuchida, T; Tsujikawa, T; Yamamoto, M; Yoshida, Y | 1 |
Arnesen, MR; Bruheim, K; Hellebust, TP; Løndalen, AM; Malinen, E; Rekstad, BL; Stokke, C | 1 |
Bourhis, J; Breuneval, T; Herrera, FG; Ozsahin, M; Prior, JO | 1 |
Denis, F; Krhili, S; Muratet, JP; Pointreau, Y; Roche, S; Septans, AL; Yossi, S | 1 |
Arnulfo, A; Brambilla, M; Buemi, F; Carriero, A; Cassarà, A; Matheoud, R; Sacchetti, GM; Stecco, A | 1 |
Eo, JS; Hong, JH; Jung, US; Kim, S; Lee, JK; Min, KJ | 1 |
Li, Y; Liu, K; Ma, Y; Wang, D; Xu, W; Yang, Z | 1 |
Andrzejewski, P; Baltzer, P; Georg, D; Georg, P; Grimm, C; Helbich, TH; Karanikas, G; Mitterhauser, M; Pinker, K; Poetter, R; Polanec, SH; Polterauer, S; Sturdza, A; Wadsak, W | 1 |
Cheng, X; Li, H; Wu, X | 1 |
Kang, WJ; Kim, S; Kim, SW; Kim, YT; Nam, EJ; Yoon, JW | 1 |
Chauhan, A; Chudgar, AV; Dubroff, JG; Mulugeta, PG | 1 |
Bae, JS; Jeon, HS; Ki, YK; Kim, DH; Kim, KH; Kim, WT; Lee, JH; Lee, JY; Nam, JH; Park, D; Suh, DS | 1 |
Acosta, O; Castelli, J; De Crevoisier, R; Devillers, A; Garin, E; Lavoue, V; Lejeune, F; Leseur, J; Ospina-Arango, JD; Roman-Jimenez, G; Terve, P; Williaume, D | 1 |
Chowdhury, F; Cooper, R; Patel, C; Scarsbrook, A; Swift, S; Vaidyanathan, S | 1 |
Lu, CH; Lu, YY; Wang, HY | 1 |
Kang, S | 1 |
Liu, C; Ma, Y; Xin, J; Xu, W; Yu, S | 1 |
Chen, Y; Fu, S; Sun, X; Wu, J; Xu, S; Yang, B; Yang, L; You, H; Yu, Y; Zhang, Y | 1 |
Cantrell, LA; Duska, LR | 1 |
Ahmad, S; Gubbi, A; Kacheria, S; Kendrick, JE; Stavitzski, NM | 1 |
Grigsby, PW; Lin, LL; Miller, TR; Schwarz, JK; Siegel, BA | 1 |
Flint, J; Hamer, OW; Manos, D; Müller, NL; Ryan, CF | 1 |
Bolcak, K; Dolezelova, H; Forbelska, M; Gombosova, J; Hynkova, L; Novotny, T; Ondrova, B; Ruzickova, J; Slampa, P; Sovadinova, S | 1 |
Alfonso, JM; Gonzalez, C; Gorospe, L; Jover, R; Lourido, D; Rojo, A | 1 |
Grigsby, PW | 6 |
Grigsby, PW; Kidd, EA | 1 |
Ferhanoğlu, B; Iğdem, A; Iğdem, S; Okkan, S; Unalan, B | 1 |
Chang, CJ; Ho, KC; Lai, CH; Lin, G; Wang, JJ; Yen, TC | 1 |
Bonardel, G; Chargari, C; Gillion, N; Haie-Meder, C; Magné, J; Magné, N; Messai, T; Vicenzi, L | 1 |
Brooks, RA; Dehdashti, F; Grigsby, PW; Mutch, DG; Powell, MA; Rader, JS; Siegel, BA; Thaker, PH | 1 |
Buist, MR; Comans, EF; Hoekstra, OS; Molthoff, CF; van Baal, MW; van der Veldt, AA | 1 |
Hong, TS; Killoran, JH; Mamede, M; Mamon, HJ | 1 |
Kang, S; Kim, M; Kim, SK; Lim, MC; Park, SY; Seo, SS | 1 |
Fong, Y; Gulec, SA; Hall, M; Pennington, K | 1 |
Baillet, G; Barre, E; Groheux, D; Hennequin, C; Hindie, E; Misset, JL; Moretti, JL; Sarandi, F; Toubert, ME | 1 |
Al Nakib, M; Brenot-Rossi, I; Buttarelli, M; De Lapparent, T; Houvenaeghel, G; Jacquemier, J; Motton, S; Tallet, A | 1 |
Chang, CC; Chen, YW; Hou, PN; Huang, MY; Lee, CS; Lian, SL | 1 |
Allen-Auerbach, M; Weber, WA | 1 |
Dehdashti, F; Delbeke, D; Grigsby, PW; Schwarz, JK | 1 |
Huang, SS; Tu, DG; Wang, KB | 1 |
Abiko, T; Koizumi, S; Takanami, I | 1 |
Cho, KS; Choi, HJ; Jung, DC; Kang, S; Kim, SK; Lee, HY; Park, SY; Seo, SS; Yoo, CW | 1 |
Chang, TC; Hong, JH; Hsueh, S; Lai, CH; Lee, SP; Ng, KK; Tsai, CS; Yen, TC | 1 |
Dehdashti, F; Grigsby, PW; Huettner, PC; Kidd, EA; Rader, JS; Siegel, BA; Spencer, CR | 1 |
El-Maghraby, T; Gambhir, SS; Iagaru, A; McDougall, IR; Mittra, E; Quon, A; Rodriguez, CA | 1 |
Bae, DS; Choi, CH; Kang, H; Kim, BG; Kim, CJ; Kim, TJ; Lee, JH; Lee, JW; Lee, YY | 1 |
Bauduceau, O; Bonardel, G; Chargari, C; Dechaud, C; Fayolle, M; Foehrenbach, H; Gontier, E; Soret, M | 1 |
Fan, W; Hu, YY; Liang, PY; Lin, XP; Sun, XR; Zhang, X | 1 |
Lurain, JR; Nemcek, A; Rademaker, A; Schink, JC; Singh, DK; Small, W; Spies, S; Vern, TZ | 1 |
Chang, TC; Chen, MY; Chen, YR; Chou, HH; Hong, JH; Lai, CH; Liu, FY; Ng, KK; Yen, TC | 1 |
Isobe, M; Iwamiya, T; Kobayashi, E; Masaki, H; Miyake, T; Nakashima, R; Shiki, Y; Yamagata, A; Yamasaki, M | 1 |
Dehdashti, F; Grigsby, PW; Kidd, EA; Mutch, DG; Mutic, S; Powell, MA; Rader, JS; Siegel, BA | 1 |
Lai, CH; Ng, KK; Yen, TC | 2 |
Bendahl, PO; Bjurberg, M; Brun, E; Kjellén, E; Ohlsson, T | 1 |
Grigsby, PW; Huettner, P; Miller, TR; Rader, J; Showalter, TN | 1 |
De La Mota, J; Espaillat-Rijo, L; Hernandez, E; Micaily, B; Thomas, MB | 1 |
Barranger, E; Bricou, A; Delpech, Y; Tulpin, L | 1 |
Chang, HP; Chang, TC; Chen, MY; Chou, HH; Hong, JH; Hsueh, S; Lai, CH; Ng, KK; Wu, TI; Yen, TC | 1 |
Dehdashti, F; Grigsby, PW; Kidd, EA; Siegel, BA | 2 |
Harry, VN | 1 |
Chung, DC; Kang, S; Kim, JY; Kim, SK; Nam, BH; Park, SY; Seo, SS | 1 |
Enomoto, T; Hatazawa, J; Higuchi, I; Imaizumi, M; Inoue, A; Isohashi, K; Kato, H; Kimura, T; Nakajo, K; Shimosegawa, E; Tatsumi, M | 1 |
Adli, M; Celen, Z; Dirier, A; Yilmaz, M; Zincirkeser, S | 1 |
Ansquer, C; Bodet-Milin, C; Bourbouloux, E; Bridji, B; Campion, L; Kraeber-Bodéré, F; Oudoux, A; Pallardy, A; Resche, I; Rousseau, C; Sagan, C; Testard, A | 1 |
Dehdashti, F; Grigsby, PW; Kidd, EA; Mutch, DG; Powell, MA; Rader, JS; Siegel, BA | 1 |
Chung, HH; Chung, JK; Kang, KW; Kang, SB; Kim, JW; Nam, BH; Park, NH; Song, YS | 1 |
Baron, M; Chastan, M; Diologent, B; Hitzel, A; Manrique, A; Sanson, AE; Vera, P | 1 |
Bentivegna, E; Duvillard, P; Gouy, S; Haie-Meder, C; Leboulleux, S; Lumbroso, J; Morice, P; Schlumberger, M; Uzan, C | 1 |
Hsieh, TC; Kao, CH; Lin, YY; Sun, SS; Wang, CH; Wu, YC; Yang, SN; Yen, KY | 1 |
Chung, DC; Kang, S; Kim, JY; Kim, SK; Lim, MC; Park, JY; Park, SH; Park, SY; Seo, SS; Song, YJ | 1 |
Dua, S; Purandare, NC; Rangarajan, V; Shah, S; Sharma, AR | 1 |
Hiramatsu, Y; Hongo, A; Kanazawa, S; Kodama, J; Nakamura, K; Okumura, Y | 1 |
Lai, CH; Yen, TC | 1 |
Duggal, BS; Goyal, BK; Jacob, MJ; Kapur, K; Singh, H | 1 |
Chuang, L; Hayes, MP; Heiba, S; Kositwattanarerk, A; Kostakoglu, L; Machac, J; Rahaman, J; Son, H; Zakashansky, K | 1 |
Chen, KY; Chiu, JS; Ho, KW; Hsu, CH; Hung, GU; Kao, CH | 1 |
Dehdashti, F; Grigsby, PW; Olsen, JR; Schwarz, JK; Siegel, BA; Zighelboim, I | 1 |
Hayasaka, K; Koyama, M; Machida, H; Takeshima, N; Takizawa, K | 1 |
Sahdev, A | 1 |
Jia, C; Lou, G; Lu, P; Tian, M; Wang, W; Wang, X; Yu, L | 1 |
Chung, HH; Chung, JK; Eo, JS; Han, KH; Kang, KW; Kang, SB; Kim, JW; Park, NH; Song, YS | 1 |
Chang, AJ; Grigsby, PW; Richardson, S; Schwarz, JK | 1 |
Bannier, M; Bats, AS; Brenot-Rossi, I; Ferron, G; Gauthier, H; Ghazzar, N; Houvenaeghel, G; Leblanc, E; Lecuru, F; Lumbroso, S; Morice, P; Narducci, F; Querleu, D; Uzan, C; Zerdoud, S | 1 |
Bernshaw, DM; Gill, S; Herschtal, A; Hicks, RJ; Narayan, K; Siva, S; Thomas, JM | 1 |
Bentivegna, E; Duvillard, P; Gouy, S; Haie-Meder, C; Leboulleux, S; Lumbroso, J; Morice, P; Uzan, C | 1 |
Coleman, RL; Euscher, ED; Frumovitz, M; Jhingran, A; Macapinlac, HA; Munsell, MF; Ramirez, PT; Ramondetta, LM; Schmeler, KM; Soliman, PT | 1 |
Bradley, KM; Gleeson, FV; Khan, Z; Nazir, SA; Patel, CN | 1 |
Ahn, SJ; Chung, WK; Jeong, JU; Jeong, SY; Nah, BS; Nam, TK; Song, JY; Yoon, MS | 1 |
Hong, IK; Kim, DY | 1 |
Grigsby, PW; Ma, DJ; Zhu, JM | 1 |
Busk, M; Horsman, MR; Jakobsen, S; Mueller-Klieser, W; Overgaard, J; Steiniche, T; Walenta, S | 1 |
Abdul-Karim, FW; Faulhaber, P; Kunos, C; Radivoyevitch, T | 1 |
Chao, A; Ho, KC; Hong, JH; Huang, KG; Huang, YT; Lai, CH; Lin, G; Qiu, JT; Wang, CC; Yen, TC | 1 |
Buda, A; Crivellaro, C; Dell'Anna, T; Fruscio, R; Guerra, L; Messa, C; Milani, R; Montanelli, L; Picchio, M; Signorelli, M | 1 |
Dehdashti, F; Grigsby, PW; Schwarz, JK; Siegel, BA | 2 |
Cheng, J; Pan, L; Yao, Z; Zhang, Y; Zhou, M | 1 |
Blanchot, J; Bouriel, C; de Crevoisier, R; Devillers, A; Fougerou, C; Garin, E; Le Prisé, E; Leseur, J; Levêque, J; Monpetit, E; Williaume, D | 1 |
Aubard, Y; Fermeaux, V; Genet, D; Leobon, S; Marin, B; Maubon, A; Monteil, J; Renaudie, J; Roux, S; Tubiana-Mathieu, N | 1 |
Chan, KW; Chan, T; Cheung, C; Hung, KN; Kwong, YL; Lopes, D | 1 |
De Meerleer, G; Delrue, L; Denys, H; Lambein, K; Lambert, B; Makar, A; Tummers, P; Van den Broecke, R; Vandecasteele, K; Villeirs, G | 1 |
Hoh, CK; Jensen, LG; Lau, SK; Liang, Y; Mell, LK; Rose, BS; Yashar, CM | 1 |
Gorospe, L; Jover-Díaz, R; Vicente-Bártulos, A | 1 |
Debaere, T; Duclos, J; Gouy, S; Haie-Meder, C; Lumbroso, J; Morice, P; Souadka, A; Uzan, C | 1 |
Blanchard, P; Dumas, I; Haie-Meder, C; Leboulleux, S; Lhomme, C; Mazeron, R; Morice, P; Paumier, A | 1 |
Choi, YJ; Huh, CY; Ki, KD; Kim, GY; Lee, JM; Lee, SK; Lim, SJ; Seol, HJ; Tong, SY | 1 |
Choi, JY; Huh, SJ; Ju, SG; Kim, BT; Kim, CK; Lee, JE; Nam, H; Park, BK; Park, W | 1 |
Dehdashti, F; Grigsby, PW; Kidd, EA; Siegel, BA; Thomas, M | 1 |
Chopra, S; Engineer, R; Mahantshetty, UM; Merchant, N; Purandare, N; Rangarajan, V; Shrivastava, SK; Thakur, M; Upasani, MN | 1 |
Bydder, GM; Bydder, M; Cornell, M; Einck, J; Fanta, P; Hoh, CK; Lawson, JD; Liang, Y; Mell, LK; Mundt, AJ; Rose, BS; Saenz, C; Yashar, CM | 1 |
Berthelsen, AK; Christensen, CB; Costa, JC; Daugaard, G; Graff, J; Loft, A; Møller, AK; Pedersen, KD; Perell, K; Petersen, BL; Skovgaard, LT | 1 |
Dehdashti, F; El Naqa, I; Grigsby, PW; Kidd, EA; Siegel, BA | 1 |
Buda, A; Crivellaro, C; De Ponti, E; Dolci, C; Fruscio, R; Guerra, L; Messa, C; Pirovano, C; Signorelli, M; Todde, S | 1 |
Frumovitz, M; Jhingran, A; Klopp, AH; Macapinlac, HA; Nick, AM; Ramirez, PT; Ramondetta, LM | 1 |
Bae, DS; Choe, YS; Choi, JY; Kim, BT; Lee, KH; Moon, SH; Park, SB; Yoo, J | 1 |
Ahn, SJ; Chung, WK; Jeong, JU; Nah, BS; Nam, TK; Song, HC; Song, JY; Yoo, SW; Yoon, MS | 1 |
Akkas, BE; Demirel, BB; Vural, GU | 1 |
Kao, PF; Lee, JK; Tseng, CJ; Weng, JH | 1 |
Barranger, E; Barré, E; Baruch-Hennequin, V; Delord, M; Delpech, Y; Groheux, D; Hindié, E; Homyrda, L; Schlageter, MH; Thoury, A; Tylski, P; Vercellino, L; Walker, F | 1 |
Dehdashti, F; DeWees, T; Esthappan, J; Grigsby, PW; Narra, VR; Olsen, JR; Schwarz, JK; Siegel, BA | 1 |
Aydin, T; Mulazimoglu, M; Tamam, MO | 1 |
Calles, L; García-Espantaleón, M; Iglesias, E; Jiménez, JS; Mucientes, J; Pereira, A; Perez-Medina, T; Rodríguez, B | 1 |
Dong, L; Eifel, PJ; Fontanilla, HP; Iyer, RB; Jhingran, A; Kelly, P; Klopp, A; Levenback, CF; Takiar, V; Zhang, Y | 1 |
Dehdashti, F; Grigsby, PW; Thomas, MA; Yang, F | 1 |
Findikcioglu, A; Onal, C; Oymak, E; Reyhan, M | 1 |
Biersack, HJ; Matthies, A; Reinhardt, MJ | 1 |
Bosch, WR; Grigsby, PW; Laforest, R; Low, DA; Malyapa, RS; Miller, TR; Mutic, S; Zoberi, I | 1 |
Albert, A; Belhocine, T; Fridman, V; Kridelka, F; Nickers, P; Rigo, P; Seidel, L; Thille, A | 1 |
Beyer, T; Townsend, DW | 1 |
Dehdashti, F; Grigsby, PW; Miller, TR; Pinkus, E | 1 |
Dehdashti, F; Grigsby, PW; Mutch, DG; Siegel, BA | 1 |
Choi, CW; Choi, SC; Kim, MH; Lee, KH; Ryu, SY | 1 |
Kawabe, J; Koyama, K; Miyama, M; Ochi, H; Okamura, T; Ozawa, N; Torii, K; Umesaki, N; Yamada, R | 1 |
Dehdashti, F; Grigsby, PW; Lewis, JS; Mintun, MA; Siegel, BA; Welch, MJ | 1 |
Hung, YC; Kao, CH; Lin, WC; Shen, YY; Yeh, LS; Yen, RF | 1 |
Dehdashti, F; Grigsby, PW; Herzog, TJ; Siegel, BA; Singh, AK | 1 |
Belhocine, T; De Barsy, C; Foidart-Willems, J; Hustinx, R; Kridelka, F; Rigo, P; Thille, A | 1 |
Berchuck, A; Clarke-Pearson, DL; Havrilesky, LJ; Jones, EL; Secord, AA; Wong, TZ | 1 |
Guo, ZM; Peng, HW; Zeng, ZY | 1 |
Aizer-Dannon, A; Bar-Am, A; Even-Sapir, E; Flusser, G; Ron, IG | 1 |
Chang, TC; Chen, JT; Chou, HH; Hong, JH; Hsueh, S; Huang, KG; Lai, CH; Lin, WJ; Lui, KW; Ma, SY; Ng, KK; See, LC; Tsai, CS; Yen, TC | 1 |
Chen, JT; Chou, HH; Hsueh, S; Lai, CH; Lin, WJ; Ma, SY; Ng, KK; See, LC; Tsai, CS; Yen, TC | 1 |
Chen, JT; Chen, WJ; Hsueh, S; Lai, CH; Lai, CR; Lin, WJ; Ma, SY; Ng, KK; See, LC; Yah-Huei, CW; Yen, TC | 1 |
Chang, TC; Chou, HH; Hong, JH; Hsueh, S; Huang, KG; Lai, CH; Ng, KK; See, LC; Tsai, CS; Yen, TC | 1 |
Even-Sapir, E; Fishman, A; Grisaru, D; Lerman, H; Lievshitz, G; Metser, U | 1 |
Bosch, WR; Dehdashti, F; Esthappan, J; Grigsby, PW; Low, DA; Malyapa, RS; Miller, TR; Mutic, S; Zoberi, I | 1 |
Chang, TC; Hong, JH; Hsueh, S; Lai, CH; Ng, KK; Tsai, CC; Tsai, CS; Yen, TC | 1 |
Huglo, D; Vinatier, D | 1 |
Dehdashti, F; Grigsby, PW; Rader, J; Siegel, BA; Zoberi, I | 1 |
Eifel, PJ | 1 |
Dehdashti, F; Grigsby, PW; Rader, J; Siegel, BA; Singh, AK; Zoberi, I | 1 |
Chang, WC; Hung, YC; Kao, CH; Lin, CC; Shen, YY | 1 |
Chang, TC; Chang, YC; Chao, A; Chen, MY; Chou, HH; Hong, JH; Hsueh, S; Huang, KG; Lai, CH; Law, KS; Lin, CT; Liou, JD; Ma, SY; Ng, KK; See, LC; Tsai, CS; Wu, TI; Yen, TC | 1 |
Ampil, FL; Charrier, A; Connor, P; Ivy, JJ; Monsour, RP; Ramaswamy, MR; Unger, JB | 1 |
Belhocine, TZ | 1 |
Chang, TC; Chang, YC; Chao, A; Fan, CC; Fu, YK; Hong, JH; Hsueh, S; Huang, KG; Lai, CH; Lin, CT; Lin, WJ; Ma, SY; Ng, KK; See, LC; Tang, SG; Tsai, CS; Yen, TC | 1 |
Fujibayashi, Y; Kawahara, K; Kotsuji, F; Kurokawa, T; Okazawa, H; Tsuchida, T; Yagihara, A; Yonekura, Y; Yoshida, Y | 1 |
Boardman, CH; Fey, GL; Lopatina, OA; Spottswood, SE | 1 |
Dehdashti, F; Grigsby, PW; Herzog, TJ; Mutch, DG; Rader, J; Siegel, BA; Zoberi, I | 1 |
Chang, TC; Chang, YC; Chou, HH; Hong, JH; Hsueh, S; Lai, CH; Ng, KK; See, LC; Tsai, CS; Yen, TC | 1 |
Hsieh, TC; Kao, CH; Liang, JA; Shiau, AC; Sun, SS; Yen, KY | 1 |
Kang, KW; Kim, SK; Lee, ES; Park, SY; Roh, JW; Sim, JS | 1 |
Havrilesky, LJ; Kulasingam, SL; Matchar, DB; Myers, ER | 1 |
Ahn, YC; Bae, DS; Choi, JY; Huh, SJ; Kim, BG; Kim, BH; Lee, J; Lim, DH; Park, W; Park, YJ | 1 |
Castelain, B; Delannes, M; Leblanc, E; Querleu, D; Sonoda, Y | 1 |
Belhocine, TZ; Jerusalem, G | 1 |
Barranger, E; Daraï, E; Grahek, D; Talbot, JN; Uzan, S | 1 |
Grosu, AL; Jeremic, B; Molls, M; Picchio, M; Piert, M; Schratzenstaller, U; Schwaiger, M; Weber, WA; Zimmermann, FB | 1 |
Grigsby, PW; Laforest, R; Lin, LL; Low, DA; Malyapa, RS; Miller, TR; Mutic, S; Vicic, M; Zoberi, I | 1 |
Ames, J; Blodgett, T; Meltzer, C | 1 |
Hasegawa, M; Ishikawa, H; Katoh, H; Kiyohara, H; Nakano, T; Nakayama, Y; Nonaka, T; Sakurai, H; Shioya, M; Suzuki, Y | 1 |
Dehdashti, F; Grigsby, PW; Lin, LL; Miller, TR; Siegel, BA; Xue, F | 1 |
Amit, A; Bar Shalom, R; Beck, D; Israel, O; Kedar, Z; Lavie, O; Lowenstein, L | 1 |
Dehdashti, F; Gao, F; Gibb, RK; Grigsby, PW; Herzog, TJ; Huettner, PC; Mutch, DG; Powell, MA; Rader, JS; Siegel, BA; Wright, JD | 1 |
Grigsby, PW; Hope, AJ; Saha, P | 1 |
Buda, A; Colombo, M; Fazio, F; Mangioni, C; Messa, C; Moreni, R; Pellegrino, A; Perego, P; Picchio, M; Sironi, S | 1 |
Chang, CJ; Chang, TC; Chao, A; Chou, HH; Hsueh, S; Huang, HJ; Huang, KG; Jung, SM; Lai, CH; Lin, CT; Ma, SY; Ng, KK; Wu, TI; Wu, YC; Yen, TC | 1 |
Macapinlac, HA | 1 |
Grigsby, PW; Lin, LL; Miller, TR; Mutic, S; Yang, Z | 1 |
Chung, HH; Kang, KW; Kim, JY; Kim, SK; Kim, TH; Lee, S; Park, SY | 1 |
De Oliveira, C; Mota, F | 1 |
Greer, BE; Rajendran, JG | 1 |
Weber, WA; Wieder, H | 1 |
Chauhan, A; Dadparvar, S; Jana, S; Kumar, R | 1 |
Berkhof, J; Buist, MR; Comans, EF; Hoekstra, OS; Hooft, L; Molthoff, CF; van der Veldt, AA; van Diest, PJ | 1 |
Chang, TC; Hong, JH; Hsueh, S; Huang, HJ; Huang, KG; Lai, CH; Lin, WJ; Ma, SY; Ng, KK; Yen, TC | 1 |
Chung, HH; Chung, JK; Jo, H; Kang, SB; Kang, WJ; Kim, JW; Lee, HP; Park, NH; Song, YS | 1 |
Grigsby, PW; LaForest, R; Lin, LL; Low, DA; Miller, TR; Mutic, S; Vicic, M; Zoberi, I | 1 |
Katsumata, N; Sawada, M | 1 |
Chang, TC; Lai, CH; Yen, TC | 1 |
Chung, HH; Chung, JK; Kang, SB; Kang, WJ; Kim, JW; Lee, HP; Park, NH; Song, YS | 1 |
Carey, BP; Coleman, RE; Grigsby, PW; Siegel, BA | 1 |
Akhurst, T; Alektiar, K; Barakat, RR; Chi, DS; Husain, A; Larson, S | 1 |
Berthelsen, AK; Engelholm, SA; Højgaard, L; Knudsen, J; Loft, A; Lundvall, L; Nedergaard, L; Ottosen, C; Roed, H | 1 |
Hofmeyr, A; Lau, WF; Slavin, MA | 1 |
Brugières, P; Capacchione, D; Créange, A; Evangelista, E; Itti, E; Kallel, F; Lefaucheur, JP; Meignan, M; Ortonne, N; Paone, G | 1 |
Alavi, A; Bural, GG; Houseni, M; Shriaknthan, S | 1 |
Dadparvar, S; Kumar, R | 1 |
Bjurberg, M; Brun, E; Kjellén, E; Ohlsson, T; Ridderheim, M | 1 |
Avci, ME; Duman, Y; Ertopcu, K; Sayhan, S; Sehirali, S; Tinar, S; Yildirim, Y; Yilmaz, C | 1 |
Chang, TC; Chao, A; Hong, JH; Hsueh, S; Lai, CH; Ng, KK; See, LC; Tsai, CS; Yen, TC | 1 |
Reinhardt, MJ | 1 |
Gold, MA | 1 |
Bae, DS; Huh, SJ; Lee, JA; Oh, D | 1 |
Oxnard, GR | 1 |
Gold, MA; Lanciano, R; Rose, PG; Tian, C; Whitney, CW | 1 |
Domeki, Y; Kaji, Y; Kitajima, K; Murakami, K; Sugimura, K; Yamasaki, E | 1 |
Boughanim, M; Duvillard, P; Haie-Meder, C; Leboulleux, S; Lumbroso, J; Morice, P; Pham, CT; Rey, A; Schlumberger, M; Zafrani, Y | 1 |
Chao, A; Cheng, HH; Ho, KC; Lai, CH; Lin, G; Wang, CC; Yen, TC | 1 |
Fujiwara, T; Fukuda, H; Ishii, K; Itoh, M; Kitamura, K; Miyake, M; Orihara, H; Satoh, T; Seo, S; Takahashi, S; Tanaka, K; Watanuki, S; Yamamoto, S | 1 |
Fukuchi, K; Hamada, S; Hayashida, K; Ishida, Y; Nakanishi, N; Nishimura, T; Satoh, T; Shimotsu, Y; Takamiya, M; Toba, M | 1 |
Eisbruch, A; Kison, PV; Kosuda, S; Recker, BE; Sugawara, Y; Wahl, RL | 1 |
Abdul-Karim, FW; Adler, LP; Faulhaber, PF; Miraldi, F; Rodriguez, M; Rose, PG | 1 |
Damgaard, K; Daugaard, G; Eigtved, A; Friberg, L; Lassen, U | 1 |
Hordijk, GJ; Stokkel, MP; Terhaard, CH; van Rijk, PP | 1 |
Ehritt-Braun, C; Högerle, S; Ihling, C; Krause, TM; Mix, M; Moser, E; Reinhardt, MJ; Vogelgesang, D | 1 |
Fischer, U; Georgi, P; Hesse, S; Horn, LC; Kluge, R; Kühnel, G; Seese, A | 1 |
Al Suhaibani, H; Bakheet, S; Kerr, IG; Manji, MF; Powe, J; Subhi, J | 1 |
Dehdashti, F; Grigsby, PW; Siegel, BA | 1 |
Achtyes, ED; Eisbruch, A; Johnston, CM; Nakamoto, Y; Reynolds, KR; Sugawara, Y; Wahl, RL | 1 |
Endo, K; Inoue, T; Mogi, K; Nakasone, Y; Negishi, A; Oriuchi, N; Takeuchi, K | 1 |
Bohuslavizki, KH; Dose, J; Hemminger, GE | 1 |
Grigsby, PW; Miller, TR | 1 |
60 review(s) available for fluorodeoxyglucose f18 and Cancer of Cervix
Article | Year |
---|---|
Radiomics model of 18F-FDG PET/CT imaging for predicting disease-free survival of early-stage uterine cervical squamous cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2022 |
Fibroblast Activation Protein Inhibitor PET Imaging in Head and Neck Cancer.
Topics: Carcinoma, Squamous Cell; Female; Fibroblasts; Fluorodeoxyglucose F18; Gallium Radioisotopes; Head and Neck Neoplasms; Humans; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Squamous Cell Carcinoma of Head and Neck; Uterine Cervical Neoplasms | 2023 |
Imaging evaluation of para-aortic lymph nodes in cervical cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2023 |
Impact of 18 F-FDG PET on the Management in Patients With Recurrent Gynecologic cancer : A Meta-analysis.
Topics: Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2023 |
FDG-PET Imaging in Cervical Cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Recurrence; Uterine Cervical Neoplasms | 2019 |
Diagnostic performance of conventional and advanced imaging modalities for assessing newly diagnosed cervical cancer: systematic review and meta-analysis.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Invasiveness; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography; Uterine Cervical Neoplasms | 2020 |
Benefits of positron emission tomography scans for the evaluation of radiotherapy.
Topics: Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Neoplasms; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Radiotherapy, Adjuvant; Rectal Neoplasms; Treatment Outcome; Uterine Cervical Neoplasms | 2020 |
[
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Uterine Cervical Neoplasms; Young Adult | 2020 |
Diagnostic Accuracy of 18F-FDG-PET/CT and MRI in Predicting the Tumor Response in Locally Advanced Cervical Carcinoma Treated by Chemoradiotherapy: A Meta-Analysis.
Topics: Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2021 |
[STAGING CERVICAL CANCER USING PET-CT AND PET-MRI].
Topics: Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2021 |
The role of
Topics: Adult; Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2017 |
[18F]-2-Fluoro-2-Deoxy-D-glucose-PET Assessment of Cervical Cancer.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Radiographic Image Enhancement; Uterine Cervical Neoplasms | 2018 |
The Role of PET Imaging in Gynecologic Radiation Oncology.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Middle Aged; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiation Oncology; Radiographic Image Enhancement; Sensitivity and Specificity; Uterine Cervical Neoplasms; Uterine Neoplasms; Vulvar Neoplasms | 2018 |
Limited additional value of cervical ultrasonography over a negative 18F-FDG PET/CT for diagnosing cervical lymph node metastases in patients with esophageal cancer: a systematic review and meta-analysis.
Topics: Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Ultrasonography; Uterine Cervical Neoplasms | 2018 |
18F-FDG PET/CT in the evaluation of cancer cervix: Where do we stand today?
Topics: Cervix Uteri; Decision Making; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Recurrence; Uterine Cervical Neoplasms | 2018 |
Prognostic Value of Volume-Based Metabolic Parameters of
Topics: Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2018 |
Cervical cancer - staging and restaging with 18F-FDG PET/CT.
Topics: Brazil; Clinical Decision-Making; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Uterine Cervical Neoplasms | 2019 |
2018 FIGO Staging System for Uterine Cervical Cancer: Enter Cross-sectional Imaging.
Topics: Cervix Uteri; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Societies, Medical; Uterine Cervical Neoplasms | 2019 |
Prognostic value of post-treatment ¹⁸F-fluorodeoxyglucose positron emission tomography in uterine cervical cancer patients treated with radiotherapy: a systematic review and meta-analysis.
Topics: Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2019 |
Prognostic value of fluorine-18-fluorodeoxyglucose positron emission tomography or PET-computed tomography in cervical cancer: a meta-analysis.
Topics: Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2013 |
The role of PET/CT in the management of cervical cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2013 |
Diagnostic value of 18F-FDG-PET or PET-CT in recurrent cervical cancer: a systematic review and meta-analysis.
Topics: Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2014 |
The role of F-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET/CT) in the screening of cervical cancer: a literature review.
Topics: Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2014 |
Application of FDG-PET in cervical cancer and endometrial cancer: utility and future prospects.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2014 |
Diagnosis of recurrent uterine cervical cancer: PET versus PET/CT: a systematic review and meta-analysis.
Topics: Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2014 |
Evaluation of gynecologic cancer with MR imaging, 18F-FDG PET/CT, and PET/MR imaging.
Topics: Coordination Complexes; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Recurrence, Local; Organometallic Compounds; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Salvage Therapy; Thiosemicarbazones; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Uterine Neoplasms | 2015 |
Prognostic Implications of the SUVmax of Primary Tumors and Metastatic Lymph Node Measured by 18F-FDG PET in Patients With Uterine Cervical Cancer: A Meta-analysis.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Positron-Emission Tomography; Prognosis; Uterine Cervical Neoplasms | 2016 |
Diuretic 18F-Fluorodeoxyglucose PET/Computed Tomography in Evaluation of Genitourinary Malignancies.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms | 2016 |
Advances in diagnosis and treatment of metastatic cervical cancer.
Topics: Bone Neoplasms; Brain Neoplasms; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Positron-Emission Tomography; Uterine Cervical Neoplasms | 2016 |
The prognostic value of PET and PET/CT in cervical cancer.
Topics: Aged; Aged, 80 and over; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2008 |
New trends in the evaluation and treatment of cervix cancer: the role of FDG-PET.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Chemotherapy, Adjuvant; Combined Modality Therapy; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Forecasting; Humans; Hysterectomy; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Postoperative Care; Preoperative Care; Prognosis; Radiotherapy, Adjuvant; Sentinel Lymph Node Biopsy; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2008 |
Nuclear imaging and cervical cancer.
Topics: Drug Monitoring; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Practice Guidelines as Topic; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Uterine Cervical Neoplasms | 2009 |
[Advantages of PET-CT in the work-up of cervical cancer].
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2009 |
Measuring response with FDG-PET: methodological aspects.
Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Adjuvant; Uterine Cervical Neoplasms | 2009 |
The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovaries.
Topics: Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2009 |
[Positron emission tomography in the management of cervix cancer patients].
Topics: Adenocarcinoma; Adult; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Uterine Cervical Neoplasms; Uterine Neoplasms | 2009 |
PET/CT imaging to guide cervical cancer therapy.
Topics: Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2009 |
Surgical and radiologic staging of cervical cancer.
Topics: Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Sentinel Lymph Node Biopsy; Uterine Cervical Neoplasms | 2010 |
[Lymph node surgical staging for locally advanced cervical cancer].
Topics: Female; Fluorodeoxyglucose F18; Humans; Laparoscopy; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2010 |
Novel imaging techniques as response biomarkers in cervical cancer.
Topics: Diagnostic Imaging; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2010 |
Diagnostic value of (18)F-FDG PET for evaluation of paraaortic nodal metastasis in patients with cervical carcinoma: a metaanalysis.
Topics: Aorta; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Positron-Emission Tomography; Uterine Cervical Neoplasms | 2010 |
Cervical tumors.
Topics: Cervix Uteri; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Uterine Cervical Diseases; Uterine Cervical Neoplasms | 2010 |
18F-FDG PET/CT of cervical carcinoma.
Topics: Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2011 |
Spectrum of PET-CT pelvic pitfalls in patients with gynecologic malignancies.
Topics: Carcinoma, Squamous Cell; Clinical Protocols; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Multimodal Imaging; Patient Positioning; Positron-Emission Tomography; Pulmonary Embolism; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2012 |
Molecular imaging in the management of cervical cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2012 |
PET-imaging in tumors of the reproductive trac.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Ovarian Neoplasms; Prostatic Neoplasms; Radiopharmaceuticals; Testicular Neoplasms; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2002 |
Staging of primary cervical cancers: the role of nuclear medicine.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2003 |
[Diagnosis of unknown primary cervical metastatic carcinoma].
Topics: Biopsy; Endoscopy; Female; Fluorodeoxyglucose F18; Humans; Neoplasms, Unknown Primary; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2003 |
Fused functional-anatomic images of metastatic cancer of cervix obtained by a combined gamma camera and an X-ray tube hybrid system with an illustrative case and review of the 18F-fluorodeoxyglucose literature.
Topics: Bone Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2003 |
[Utilization of PET scan in breast and gynaecologic cancers].
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Ovarian Neoplasms; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2004 |
[Role of [18F]-fluorodeoxyglucose positron emission tomography for the initial detection, staging, search for recurrences and restaging of gynaecological and breast cancers].
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Uterine Cervical Neoplasms; Uterine Neoplasms | 2005 |
Positron emission tomography for radiation treatment planning.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Neoplasms; Neoplasms, Unknown Primary; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Prostatic Neoplasms; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2005 |
Patients with locally advanced cervical cancer should not undergo routine pretreatment surgical staging.
Topics: Algorithms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2006 |
Expanding role of positron emission tomography in cancer of the uterine cervix.
Topics: Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2006 |
Monitoring chemotherapy and radiotherapy of solid tumors.
Topics: Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Monitoring, Physiologic; Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Sarcoma; Uterine Cervical Neoplasms | 2006 |
Positron emission tomography in gynecological malignancies.
Topics: Adult; Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2006 |
Positron emission tomography imaging for gynecologic malignancy.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2007 |
Medicare coverage of PET for cervical cancer.
Topics: Centers for Medicare and Medicaid Services, U.S.; Female; Fluorodeoxyglucose F18; Humans; Insurance Coverage; Medicare; Positron-Emission Tomography; Radiopharmaceuticals; Registries; United States; Uterine Cervical Neoplasms | 2006 |
Gynecologic tumors.
Topics: Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2008 |
PET in cervical cancer--implications for 'staging,' treatment planning, assessment of prognosis, and prediction of response.
Topics: Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Uterine Cervical Neoplasms | 2008 |
30 trial(s) available for fluorodeoxyglucose f18 and Cancer of Cervix
Article | Year |
---|---|
A Multi-atlas Approach for Active Bone Marrow Sparing Radiation Therapy: Implementation in the NRG-GY006 Trial.
Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Chemoradiotherapy; Feasibility Studies; Female; Femur Head; Fluorodeoxyglucose F18; Humans; Intestines; Linear Models; Medical Illustration; Middle Aged; Organ Sparing Treatments; Organs at Risk; Pelvic Bones; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Rectum; Urinary Bladder; Uterine Cervical Neoplasms | 2020 |
Roles of posttherapy
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Failure; Uterine Cervical Neoplasms | 2018 |
Pilot study of combined FDG-PET and dynamic contrast-enhanced CT of locally advanced cervical carcinoma before and during concurrent chemoradiotherapy suggests association between changes in tumor blood volume and treatment response.
Topics: Adult; Aged; Blood Volume; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Neovascularization, Pathologic; Pilot Projects; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2018 |
Effect of Positron Emission Tomography Imaging in Women With Locally Advanced Cervical Cancer: A Randomized Clinical Trial.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Ontario; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2018 |
Fluorodeoxyglucose Positron Emission Tomography integrated with computed tomography in carcinoma of the cervix: Its impact on accurate staging and the predictive role of its metabolic parameters.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2019 |
Changes on Midchemoradiation Therapy Fluorodeoxyglucose Positron Emission Tomography for Cervical Cancer Are Associated with Prognosis.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Chemoradiotherapy; Cisplatin; Confidence Intervals; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymph Nodes; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Prospective Studies; Radiation-Sensitizing Agents; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Treatment Outcome; Uterine Cervical Neoplasms; Young Adult | 2019 |
Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Topotecan; Uterine Cervical Neoplasms; Young Adult | 2013 |
Radiochemotherapy plus 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in advanced-stage cervical and vaginal cancers.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Chemoradiotherapy; Cisplatin; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Pyridines; Thiosemicarbazones; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Vaginal Neoplasms | 2013 |
Prospective evaluation of qualitative and quantitative ¹⁸F-FDG PET-CT parameters for predicting survival in recurrent carcinoma of the cervix.
Topics: Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Recurrence; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2013 |
Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography-computed tomography for response evaluation in recurrent carcinoma cervix: does metabolic response predict survival?
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; India; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Survival; Uterine Cervical Neoplasms | 2014 |
The Role of Pretreatment FDG-PET in Treating Cervical Cancer Patients With Enlarged Pelvic Lymph Node(s) Shown on MRI: A Phase 3 Randomized Trial With Long-Term Follow-Up.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Pelvis; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiation-Protective Agents; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2015 |
¹⁸F-FDG PET/CT following chemoradiation of uterine cervix cancer provides powerful prognostic stratification independent of HPV status: a prospective cohort of 105 women with mature survival data.
Topics: Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Papillomaviridae; Positron-Emission Tomography; Prospective Studies; Salvage Therapy; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2015 |
Additional Prognostic Value of SUVmax Measured by F-18 FDG PET/CT over Biological Marker Expressions in Surgically Resected Cervical Cancer Patients.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Biomarkers; Carbonic Anhydrase IX; Carbonic Anhydrases; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2015 |
Intratumoral metabolic heterogeneity of cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Kaplan-Meier Estimate; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy; Uterine Cervical Neoplasms | 2008 |
A prospective randomized trial to study the impact of pretreatment FDG-PET for cervical cancer patients with MRI-detected positive pelvic but negative para-aortic lymphadenopathy.
Topics: Adult; Aged; Aorta; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Pelvis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Uterine Cervical Neoplasms | 2010 |
Prediction of patient outcome with 2-deoxy-2-[18F]fluoro-D-glucose-positron emission tomography early during radiotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Carcinoma, Squamous Cell; Disease Progression; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Positron-Emission Tomography; Prognosis; Survival Analysis; Time Factors; Treatment Outcome; Uterine Cervical Neoplasms | 2009 |
Evaluation of ¹⁸F-FDG PET/CT in early-stage cervical carcinoma.
Topics: Adenocarcinoma; Adult; Carcinoma, Squamous Cell; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2011 |
Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical cancer: a prospective correlation of surgical findings with positron emission tomography/computed tomography findings.
Topics: Aorta; Female; Fluorodeoxyglucose F18; Humans; Laparoscopy; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2011 |
18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2012 |
Prospective evaluation of 18-fluoro-2-deoxy-D-glucose positron emission tomography for the discrimination of paraaortic nodal spread in patients with locally advanced cervical carcinoma.
Topics: Adult; Aged; Aorta, Abdominal; Carcinoma, Squamous Cell; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Uterine Cervical Neoplasms | 2013 |
Isolated mediastinal lymph node false positivity of [18F]-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Mediastinal Neoplasms; Mediastinoscopy; Mediastinum; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2013 |
Usefulness of (18)F-fluorodeoxyglucose positron emission tomography to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomography findings.
Topics: Adult; Aorta, Abdominal; False Negative Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2003 |
18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Middle Aged; Monosaccharide Transport Proteins; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Uterine Cervical Neoplasms | 2004 |
Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT.
Topics: Endometrial Neoplasms; Endometrium; Female; Fluorodeoxyglucose F18; Humans; Menstrual Cycle; Middle Aged; Ovarian Neoplasms; Ovary; Postmenopause; Premenopause; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2004 |
Usefulness of FDG-PET to detect recurrent cervical cancer based on asymptomatically elevated tumor marker serum levels--a preliminary report.
Topics: Adult; Antigens, Neoplasm; Biomarkers, Tumor; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2004 |
Positron emission tomography for unexplained elevation of serum squamous cell carcinoma antigen levels during follow-up for patients with cervical malignancies: a phase II study.
Topics: Antigens, Neoplasm; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Predictive Value of Tests; Serpins; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2004 |
Defining the priority of using 18F-FDG PET for recurrent cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Analysis; Treatment Outcome; Uterine Cervical Neoplasms | 2004 |
Does diabetes mellitus influence the efficacy of FDG-PET in the diagnosis of cervical cancer?
Topics: Adult; Aged; Aged, 80 and over; Artifacts; Diabetes Complications; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Uterine Cervical Neoplasms | 2005 |
The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study.
Topics: Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2007 |
Prognostic value of positron emission tomography using F-18-fluorodeoxyglucose in patients with cervical cancer undergoing radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2002 |
348 other study(ies) available for fluorodeoxyglucose f18 and Cancer of Cervix
Article | Year |
---|---|
Prognostic Value of FDG PET/CT in Patients With Neuroendocrine Carcinoma of the Uterine Cervix.
Topics: Carcinoma, Neuroendocrine; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden; Uterine Cervical Neoplasms | 2021 |
Sacral Insufficiency Fracture after Radiotherapy for Cervical Cancer: Appearance and Dynamic Changes on 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Fractures, Stress; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sacrum; Uterine Cervical Neoplasms | 2021 |
The value of metabolic parameters and textural analysis in predicting prognosis in locally advanced cervical cancer treated with chemoradiotherapy.
Topics: Antigens, Neoplasm; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Hydronephrosis; Keratin-19; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden; Uterine Cervical Neoplasms | 2022 |
First experiences with PET-MRI/CT in radiotherapy planning for cervical cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2022 |
Interest of para-aortic lymphadenectomy for locally advanced cervical cancer in the era of PET scanning.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Uterine Cervical Neoplasms | 2022 |
Incidental Diagnosis of Right Renal Subcapsular Urinoma on an 18 F-FDG PET/CT Scan Performed for Staging of Cervical Cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Urinoma; Uterine Cervical Neoplasms | 2022 |
Management and prognosis of cervical cancer patients treated with definitive radiation therapy who have partial metabolic response on post-therapy positron emission tomography.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2022 |
Deep learning-based multimodal image analysis for cervical cancer detection.
Topics: Deep Learning; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Uterine Cervical Neoplasms | 2022 |
An Exploratory Study of Neoadjuvant Cetuximab Followed by Cetuximab and Chemoradiotherapy in Women With Newly Diagnosed Locally Advanced Cervical Cancer.
Topics: Cetuximab; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Precision Medicine; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2022 |
Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms | 2022 |
The value of the SUV ratio between lymph node and bone marrow in predicting pelvic lymphatic metastasis of patients with locally advanced cervical cancer: an integrated PET/CT study.
Topics: Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms | 2022 |
Improved stratification of stage-specific survival for cervical uterine cancer by integrating FDG-PET/CT and MRI for lymph node staging in 2018 FIGO classification.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Uterine Cervical Neoplasms; Uterine Neoplasms | 2022 |
FDG PET-CT as an important diagnostic tool and prognostic marker in suspected recurrent cervical carcinoma after radiotherapy: comparison with MRI.
Topics: Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Uterine Cervical Neoplasms | 2022 |
Prognostic value of textural features obtained from F-fluorodeoxyglucose (F-18 FDG) positron emission tomography/computed tomography (PET/CT) in patients with locally advanced cervical cancer undergoing concurrent chemoradiotherapy.
Topics: Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2023 |
First Clinical Experience With [68Ga]Ga-FAPI-46-PET/CT Versus [18F]F-FDG PET/CT for Nodal Staging in Cervical Cancer.
Topics: Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tumor Microenvironment; Uterine Cervical Neoplasms | 2023 |
Cervix Abscess Mimicking Cervical Cancer Explored With 18 F-FDG PET/CT and MRI.
Topics: Abscess; Adult; Cervix Uteri; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2023 |
Metabolic parameters of [
Topics: Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden; Uterine Cervical Neoplasms | 2023 |
PET-MRI for evaluation of response to radiochemotherapy in patients with locally advanced cervical cancer.
Topics: Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2023 |
Utility of pre-treatment 18 F-fluorodeoxyglucose PET radiomic analysis in assessing nodal involvement in cervical cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tumor Burden; Uterine Cervical Neoplasms | 2023 |
Multicentric development and evaluation of
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Uterine Cervical Neoplasms | 2023 |
A common [18F]-FDG PET radiomic signature to predict survival in patients with HPV-induced cancers.
Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Human Papillomavirus Viruses; Humans; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Uterine Cervical Neoplasms | 2023 |
Prognostic significance of delayed complete metabolic response on PET/CT after primary chemoradiation treatment of cervical cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms | 2023 |
Head-to-Head Comparison of 18 F-FDG and 68 Ga-FAPI-04 PET/CT for Radiological Evaluation of Cervical Cancer.
Topics: Adult; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Uterine Cervical Neoplasms | 2023 |
PET/CT scan improves detection of metastatic disease compared with CT scan alone in women with high-grade neuroendocrine cervical cancer: a NeCTuR study.
Topics: Carcinoma, Neuroendocrine; Cervix Uteri; Female; Fluorodeoxyglucose F18; Humans; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2023 |
Prognostic value of
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms | 2023 |
Evaluation of parametrial infiltration in cervical cancer with voxel-based segmentation of integrated
Topics: Adult; Aged; Cervix Uteri; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Uterine Cervical Neoplasms; Young Adult | 2019 |
Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms; Young Adult | 2019 |
Multiparametric PET/MR (PET and MR-IVIM) for the evaluation of early treatment response and prediction of tumor recurrence in patients with locally advanced cervical cancer.
Topics: Adult; Aged; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multiparametric Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Pelvis; Positron-Emission Tomography; Treatment Outcome; Uterine Cervical Neoplasms | 2020 |
Added value of para-aortic surgical staging compared to
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Aorta; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Intraoperative Complications; Lymph Node Excision; Lymph Nodes; Middle Aged; Neoplasm Staging; Pelvis; Positron Emission Tomography Computed Tomography; Postoperative Complications; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms; Young Adult | 2020 |
Tumour and pelvic lymph node metabolic activity on FDG-PET/CT to stratify patients for para-aortic surgical staging in locally advanced cervical cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms | 2020 |
Pretreatment tumor-related leukocytosis misleads positron emission tomography-computed tomography during lymph node staging in gynecological malignancies.
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Humans; Leukocytosis; Lymph Nodes; Middle Aged; Neoplasms; Positron Emission Tomography Computed Tomography; Uterine Cervical Neoplasms | 2020 |
Is there any correlation between HPV and early radioresponse before brachytherapy in cervix uteri carcinoma?
Topics: Aged; Aged, 80 and over; Brachytherapy; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Papillomaviridae; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Treatment Outcome; Tumor Burden; Uterine Cervical Neoplasms | 2020 |
Radiation Recall Myositis Detected With 18F-FDG PET/CT After a Treatment of Cervical Cancer.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Myositis; Positron Emission Tomography Computed Tomography; Radiation Injuries; Treatment Outcome; Uterine Cervical Neoplasms | 2020 |
18F-Fluciclovine PET/MRI in a Patient With Squamous Cell Carcinoma of the Uterine Cervix Correlated With 18F-FDG PET/CT.
Topics: Adult; Carboxylic Acids; Carcinoma, Squamous Cell; Cyclobutanes; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Uterine Cervical Neoplasms | 2020 |
PET-detected asymptomatic recurrence is associated with improved survival in recurrent cervical cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Uterine Cervical Neoplasms | 2021 |
Pre-treatment prediction of early response to chemoradiotherapy by quantitative analysis of baseline staging FDG-PET/CT and MRI in locally advanced cervical cancer.
Topics: Adult; Aged; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Treatment Outcome; Uterine Cervical Neoplasms | 2021 |
Splenic
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Liver; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Spleen; Uterine Cervical Neoplasms | 2020 |
The feasibility of
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2020 |
Editorial for: "PET/MRI in Cervical Cancer: Associations Between Imaging Biomarkers and Tumor Stage, Disease Progression, and Overall Survival".
Topics: Biomarkers; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2021 |
EANM/SNMMI practice guideline for [
Topics: Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2021 |
Optimal method for metabolic tumour volume assessment of cervical cancers with inter-observer agreement on [18F]-fluoro-deoxy-glucose positron emission tomography with computed tomography.
Topics: Female; Fluorodeoxyglucose F18; Glucose; Humans; Observer Variation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tumor Burden; Uterine Cervical Neoplasms | 2021 |
Early Metabolic Response Assessed Using 18F-FDG-PET/CT for Image-Guided Intracavitary Brachytherapy Can Better Predict Treatment Outcomes in Patients with Cervical Cancer.
Topics: Adenocarcinoma; Brachytherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Risk Assessment; Survival Rate; Uterine Cervical Neoplasms | 2021 |
Relationship between tumor heterogeneity and volume in cervical cancer: Evidence from integrated fluorodeoxyglucose 18 PET/MR texture analysis.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Tumor Burden; Uterine Cervical Neoplasms | 2021 |
Mediastinal Recurrence of Uterine Cervix Cancer on 18F-FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Mediastinal Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Recurrence; Uterine Cervical Neoplasms | 2021 |
Diagnostic efficiency of whole-body
Topics: Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Reference Standards; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2021 |
[Para-aortic lymph node staging in grade IB2 and above cervical cancers: Comparison of 18FDG PET-CT with para-aortic lymphadenectomy, using data from the Côte d'Or gynaecological cancer registry from 2003 to 2016].
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Registries; Retrospective Studies; Uterine Cervical Neoplasms | 2021 |
False negative rate at
Topics: Adenocarcinoma; Adult; Aged; Aorta; Carcinoma, Squamous Cell; Chemoradiotherapy; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Laparoscopy; Lymph Node Excision; Lymph Nodes; Middle Aged; Neoplasm Staging; Pelvis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms; Young Adult | 2021 |
Long-Term Outcomes of Cervical Cancer Patients Treated With Definitive Chemoradiation Following a Complete Metabolic Response.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Positron-Emission Tomography; Retrospective Studies; Uterine Cervical Neoplasms | 2021 |
Volumetric PET parameters are predictive for the prognosis of locally advanced cervical cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Tumor Burden; Uterine Cervical Neoplasms | 2023 |
[
Topics: Bayes Theorem; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Uterine Cervical Neoplasms | 2021 |
PET/MR imaging for the evaluation of cervical cancer during pregnancy.
Topics: Adult; Cervix Uteri; Disease Progression; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Staging; Papanicolaou Test; Positron-Emission Tomography; Pregnancy; Pregnancy Complications, Neoplastic; Preoperative Period; Radiopharmaceuticals; Uterine Cervical Neoplasms; Vaginal Smears | 2021 |
Staging, recurrence and follow-up of uterine cervical cancer using MRI: Updated Guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018.
Topics: Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiology; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2021 |
Standardized Uptake Value Illuminates Tumor Inflammation and Treatment Response.
Topics: Female; Fluorodeoxyglucose F18; Humans; Inflammation; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tumor Microenvironment; Uterine Cervical Neoplasms | 2021 |
Sentinel lymph node mapping in early-stage cervical cancer - A national prospective multicenter study (SENTIREC trial).
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Indocyanine Green; Lymph Nodes; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Sentinel Lymph Node; Uterine Cervical Neoplasms | 2021 |
Prediction of lymphovascular space invasion using a combination of tenascin-C, cox-2, and PET/CT radiomics in patients with early-stage cervical squamous cell carcinoma.
Topics: Adult; Aged; Biomarkers; Cyclooxygenase 2; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Lymphatic Metastasis; Machine Learning; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Retrospective Studies; ROC Curve; Tenascin; Uterine Cervical Neoplasms | 2021 |
Long-term outcomes of cervical cancer patients with complete metabolic response after definitive chemoradiotherapy.
Topics: Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden; Uterine Cervical Neoplasms | 2021 |
Random forests to predict tumor recurrence following cervical cancer therapy using pre- and per-treatment
Topics: Aged; Algorithms; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Uterine Cervical Neoplasms | 2016 |
Prognostic Value of Fluorine-18 Fluorodeoxyglucose Uptake of Bone Marrow on Positron Emission Tomography/Computed Tomography for Prediction of Disease Progression in Cervical Cancer.
Topics: Adult; Aged; Bone Marrow; Chemoradiotherapy; Cytoreduction Surgical Procedures; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Inflammation Mediators; Lymph Node Excision; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms | 2017 |
Survival of Cervical Cancer Patients Presenting with Occult Supraclavicular Metastases Detected by FDG-Positron Emission Tomography/CT: Impact of Disease Extent and Treatment.
Topics: Adult; Aged; Chemoradiotherapy; Clavicle; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Palliative Care; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Time Factors; Treatment Outcome; Uterine Cervical Neoplasms | 2018 |
[18]Fluorodeoxyglucose Positron Emission Tomography for the Textural Features of Cervical Cancer Associated with Lymph Node Metastasis and Histological Type.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Uterine Cervical Neoplasms; Young Adult | 2017 |
Parameters of simultaneous 18F-FDG-PET/MRI predict tumor stage and several histopathological features in uterine cervical cancer.
Topics: Adult; Aged; Biomarkers; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Uterine Cervical Neoplasms | 2017 |
Irreversible Electroporation to Treat Malignant Tumor Recurrences Within the Pelvic Cavity: A Case Series.
Topics: Aged; Carcinoma, Renal Cell; Electroporation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; Sigmoid Neoplasms; Treatment Outcome; Uterine Cervical Neoplasms | 2017 |
Comparison of FDG PET metabolic tumour volume versus ADC histogram: prognostic value of tumour treatment response and survival in patients with locally advanced uterine cervical cancer.
Topics: Adult; Aged; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Treatment Outcome; Tumor Burden; Uterine Cervical Neoplasms | 2017 |
Feasibility of atlas-based active bone marrow sparing intensity modulated radiation therapy for cervical cancer.
Topics: Adult; Aged; Bone Marrow; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Uterine Cervical Neoplasms | 2017 |
Prognostic value of metabolic parameters determined by preoperative ¹⁸F-FDG PET/CT in patients with uterine carcinosarcoma.
Topics: Adult; Aged; Carcinosarcoma; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Preoperative Period; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Survival Rate; Tumor Burden; Uterine Cervical Neoplasms | 2017 |
Prediction of cervical cancer recurrence using textural features extracted from 18F-FDG PET images acquired with different scanners.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2017 |
Primary Cutaneous Angiosarcoma Mimicking Metastasis on 18F-FDG PET/CT in Woman With Cervix Cancer.
Topics: Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Skin Neoplasms; Uterine Cervical Neoplasms | 2017 |
The combination of preoperative PET/CT and sentinel lymph node biopsy in the surgical management of early-stage cervical cancer.
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Carcinoma, Adenosquamous; Carcinoma, Neuroendocrine; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sentinel Lymph Node; Sentinel Lymph Node Biopsy; Uterine Cervical Neoplasms | 2017 |
Comparison of
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2018 |
A score combining baseline neutrophilia and primary tumor SUV
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Brachytherapy; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Middle Aged; Neoplasm Grading; Neutrophils; Positron-Emission Tomography; Prognosis; Retrospective Studies; Uterine Cervical Neoplasms | 2018 |
An Unusual Presentation of Cervical Carcinoma Metastasis as Mediastinal Adenopathy.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchoscopy; Female; Fluorodeoxyglucose F18; Humans; Lymphadenopathy; Mediastinal Diseases; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Treatment Outcome; Uterine Cervical Neoplasms | 2017 |
Port-Site Metastasis of Uterine Carcinosarcoma after Laparoscopy.
Topics: Abdominal Neoplasms; Carcinoma, Squamous Cell; Carcinosarcoma; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Keratin-5; Laparoscopy; Middle Aged; Positron Emission Tomography Computed Tomography; Uterine Cervical Neoplasms | 2017 |
Uncommon Metastasis to the Pancreas From Adenocarcinoma of the Cervix Detected on Surveillance 18F-FDG PET/CT Imaging.
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Uterine Cervical Neoplasms | 2017 |
Comparison of positron emission tomography/computed tomography and magnetic resonance imaging for posttherapy evaluation in patients with advanced cervical cancer receiving definitive concurrent chemoradiotherapy.
Topics: Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2018 |
Concordance of FDG PET/CT metabolic tumour volume versus DW-MRI functional tumour volume with T2-weighted anatomical tumour volume in cervical cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tumor Burden; Uterine Cervical Neoplasms | 2017 |
Prediction of outcome using pretreatment
Topics: Adult; Aged; Aged, 80 and over; Bayes Theorem; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2018 |
Pretreatment metabolic tumour volume and total lesion glycolysis are not independent prognosticators for locally advanced cervical cancer patients treated with chemoradiotherapy.
Topics: Aged; Biopsy; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tumor Burden; Uterine Cervical Neoplasms | 2018 |
Evaluating the Role of F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scanning in the Staging of Patients With Stage IIIB Cervical Carcinoma and the Impact on Treatment Decisions.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Decision Making; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Uterine Cervical Neoplasms; Young Adult | 2018 |
Prognostic Impact of Pretreatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography SUVmax in Patients With Locally Advanced Cervical Cancer.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Survival Analysis; Uterine Cervical Neoplasms | 2018 |
Usefulness of the maximum standardized uptake value for the diagnosis and staging of patients with cervical cancer undergoing positron emission tomography/computed tomography.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Reference Standards; Retrospective Studies; ROC Curve; Uterine Cervical Neoplasms | 2018 |
Prognostic significance of residual lymph node status after definitive chemoradiotherapy in patients with node-positive cervical cancer.
Topics: Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Prognosis; Uterine Cervical Neoplasms | 2018 |
An atlas to aid delineation of para-aortic lymph node region in cervical cancer: Design and validation of contouring guidelines.
Topics: Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Prospective Studies; Reproducibility of Results; Uterine Cervical Neoplasms | 2018 |
(
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Survival Rate; Uterine Cervical Neoplasms | 2018 |
Which is better for predicting pelvic lymph node metastases in patients with cervical cancer: Fluorodeoxyglucose-positron emission tomography/computed tomography or a sentinel node biopsy? A retrospective observational study.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Pelvic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Uterine Cervical Neoplasms | 2018 |
[Application of (18)F-fluorodeoxyglucose Metabolic Imaging in Diagnosis and Treatment of Cervical Cancer].
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Pelvis; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Single Photon Emission Computed Tomography Computed Tomography; Uterine Cervical Neoplasms | 2016 |
18F-FDG-PET/CT guided external beam radiotherapy volumes in inoperable uterine cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiotherapy, Image-Guided; Retrospective Studies; Survival Analysis; Uterine Cervical Neoplasms | 2018 |
Prognostic Value of Pretreatment Metabolic PET Parameters in Cervical Cancer Patients With Metabolic Complete Response After Concurrent Chemoradiotherapy.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2018 |
Prognostic value of posttreatment
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Treatment Outcome; Uterine Cervical Neoplasms | 2018 |
Predictive Value of FDG PET/CT to Detect Lymph Node Metastases in Cervical Cancer.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies; Sensitivity and Specificity; Uterine Cervical Neoplasms | 2018 |
Cervical Cancer Presenting as an Omental Cake.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Omentum; Positron Emission Tomography Computed Tomography; Uterine Cervical Neoplasms | 2018 |
Evaluation of 18F-FDG PET/CT parameters for reflection of aggressiveness and prediction of prognosis in early-stage cervical cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Survival Analysis; Uterine Cervical Neoplasms | 2018 |
Correlation between tumor glucose metabolism and multiparametric functional MRI (IVIM and R2*) metrics in cervical carcinoma: Evidence from integrated
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms; Vascular Endothelial Growth Factor A | 2019 |
Less Than Whole Uterus Irradiation for Locally Advanced Cervical Cancer Maintains Locoregional Control and Decreases Radiation Dose to Bowel.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Cervix Uteri; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Intestines; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Organs at Risk; Positron Emission Tomography Computed Tomography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 2019 |
Amide proton transfer imaging to evaluate the grading of squamous cell carcinoma of the cervix: A comparative study using
Topics: Amides; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Observer Variation; Positron-Emission Tomography; Prospective Studies; Protons; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2019 |
Intensity Modulated Radiation Therapy and Image-Guided Adapted Brachytherapy for Cervix Cancer.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Tract; Humans; Kaplan-Meier Estimate; Lymph Nodes; Middle Aged; Neoplasm Recurrence, Local; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Survival Rate; Time Factors; Urogenital System; Uterine Cervical Neoplasms; Young Adult | 2019 |
Metabolo-volumetric parameters of 18F-FDG-PET can predict expression of EGFR and HIF 1alpha in uterine cervical cancer.
Topics: Aged; Biomarkers; ErbB Receptors; Female; Fluorodeoxyglucose F18; Gene Expression; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Middle Aged; Neoplasm Grading; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Uterine Cervical Neoplasms | 2019 |
External validation of a combined PET and MRI radiomics model for prediction of recurrence in cervical cancer patients treated with chemoradiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Bias; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Treatment Outcome; Uterine Cervical Neoplasms | 2019 |
The efficacy of pretreatment and after treatment 18F-FDG PET/CT metabolic parameters in patients with locally advanced squamous cell cervical cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 2019 |
Chemoradiotherapy for locally advanced cervix cancer without aortic lymph node involvement: can we consider metabolic parameters of pretherapeutic FDG-PET/CT for treatment tailoring?
Topics: Adult; Aged; Aorta; Biomarkers, Tumor; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 2019 |
Detection of distant metastatic disease by positron emission tomography with
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms; Whole Body Imaging | 2019 |
Influence of 18F-FDG-PET/CT on staging of cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Uterine Cervical Neoplasms | 2019 |
Clinical outcomes after isolated pelvic failure in cervical cancer patients treated with definitive radiation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Aorta; Bone Neoplasms; Brachytherapy; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Pelvic Exenteration; Pelvis; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Salvage Therapy; Survival Rate; Uterine Cervical Neoplasms | 2019 |
Combinative evaluation of primary tumor and lymph nodes in predicting pelvic lymphatic metastasis in early-stage cervical cancer: A multiparametric PET-CT study.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pelvic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tumor Burden; Uterine Cervical Neoplasms | 2019 |
Volumetric assessment of apparent diffusion coefficient predicts outcome following chemoradiation for cervical cancer.
Topics: Adult; Aged; Chemoradiotherapy; Diffusion Magnetic Resonance Imaging; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Retrospective Studies; Uterine Cervical Neoplasms | 2019 |
Enhancing prognosis prediction using pre-treatment nodal SUVmax and HPV status in cervical squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Alphapapillomavirus; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2019 |
Influence of Biological Parameters Assessed in [18F]FDG PET/CT on Overall Survival in Cervical Cancer Patients.
Topics: Adult; Aged; Biological Transport; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Survival Rate; Tumor Burden; Uterine Cervical Neoplasms | 2019 |
18F-FDG PET/CT makes a significant contribution to diagnosis of malignancy in patients with cervical lymphadenopathy: a study using optimal scale regression tests.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Diseases; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2013 |
Correlation between biological marker expression and F-fluorodeoxyglucose uptake in cervical cancer measured by positron emission tomography.
Topics: Adult; Aged; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Proteins; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Uterine Cervical Neoplasms | 2013 |
To operate or to radiate: the added value of the maximal standardized uptake value in PET-FDG in cervical cancer patients.
Topics: Analysis of Variance; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2013 |
[Adrenal cortical adenoma with increased uptake of 18F-fluoro-deoxy-glucose on PET/CT suspected as an adrenal metastasis from the cervical cancer : a case report].
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2013 |
In vitro chemoresponse to cisplatin and outcomes in cervical cancer.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Drug Screening Assays, Antitumor; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Proportional Hazards Models; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 2013 |
Condyloma acuminata induces focal intense FDG uptake mimicking vaginal stump recurrence from uterine cervical cancer: a case report.
Topics: Adult; Condylomata Acuminata; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Vagina | 2013 |
Perineural spread of cervical cancer to the sciatic nerve.
Topics: Adenocarcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Peripheral Nervous System Neoplasms; Radiopharmaceuticals; Rare Diseases; Sciatic Neuropathy; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2013 |
Prognostic value of pretreatment 18F-fluorodeoxyglucose uptake in patients with cervical cancer treated with definitive chemoradiotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Young Adult | 2013 |
Hepatic adenoma mimicking a metastatic lesion on computed tomography-positron emission tomography scan.
Topics: Adenoma; Adult; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hysterectomy; Liver Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2013 |
Translating imaging results into tumor biology: FDG-PET and the response to chemoradiation in human cervical carcinoma.
Topics: Antineoplastic Agents; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Humans; Phosphatidylinositol 3-Kinases; Phosphorylation; Positron-Emission Tomography; Proto-Oncogene Proteins c-akt; Radiopharmaceuticals; Radiotherapy; Treatment Outcome; Uterine Cervical Neoplasms | 2013 |
Prognostic significance of tumor response as assessed by sequential 18F-fluorodeoxyglucose-positron emission tomography/computed tomography during concurrent chemoradiation therapy for cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Brachytherapy; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Conformal; ROC Curve; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2013 |
Clinical impact of 2-deoxy-2-[18F]fluoro-D-glucose (FDG)-positron emission tomography (PET) on treatment choice in recurrent cancer of the cervix uteri.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Choice Behavior; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Positron-Emission Tomography; Recurrence; Uterine Cervical Neoplasms | 2013 |
Preoperative PET/CT FDG standardized uptake value of pelvic lymph nodes as a significant prognostic factor in patients with uterine cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Middle Aged; Multimodal Imaging; Pelvis; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Period; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2014 |
Prognostic implication of retrocrural lymph node involvement revealed by (18)F-FDG PET/CT in patients with uterine cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Young Adult | 2014 |
The effect of small tumor volumes on studies of intratumoral heterogeneity of tracer uptake.
Topics: Computer Simulation; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Positron-Emission Tomography; Probability; Radiopharmaceuticals; Retrospective Studies; Tumor Burden; Uterine Cervical Neoplasms | 2014 |
Determination of an optimal standardized uptake value of fluorodeoxyglucose for positron emission tomography imaging to assess pathological volumes of cervical cancer: a prospective study.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Reference Values; Tomography, X-Ray Computed; Tumor Burden; Uterine Cervical Neoplasms | 2013 |
Enhanced CT and FDG PET/CT in primary malignant peripheral nerve sheath tumor of the uterine cervix.
Topics: Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neurilemmoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2014 |
FDG uptake heterogeneity in FIGO IIb cervical carcinoma does not predict pelvic lymph node involvement.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Pelvis; Positron-Emission Tomography; Principal Component Analysis; Prognosis; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 2013 |
Anatomical and functional volume concordance between FDG PET, and T2 and diffusion-weighted MRI for cervical cancer: a hybrid PET/MR study.
Topics: Adult; Aged; Carcinoma; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2014 |
Combined measurement of tumor perfusion and glucose metabolism for improved tumor characterization in advanced cervical carcinoma. A PET/CT pilot study using [15O]water and [18F]fluorodeoxyglucose.
Topics: Adult; Aged; Blood Glucose; Cervix Uteri; Chemoradiotherapy; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Oxygen Radioisotopes; Perfusion Imaging; Pilot Projects; Positron-Emission Tomography; Regional Blood Flow; Retrospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2014 |
Comparison of tumor volume between PET and MRI in cervical cancer with hybrid PET/MR.
Topics: Adult; Aged; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tumor Burden; Uterine Cervical Neoplasms | 2014 |
IMRT with ¹⁸FDG-PET\\CT based simultaneous integrated boost for treatment of nodal positive cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Survival Rate; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2014 |
Defining PET tumor volume in cervical cancer with hybrid PET/MRI: a comparative study.
Topics: Adult; Aged; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tumor Burden; Uterine Cervical Neoplasms | 2014 |
Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer.
Topics: Adult; Aged; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Young Adult | 2014 |
Correlation of standardized uptake value and apparent diffusion coefficient in integrated whole-body PET/MRI of primary and recurrent cervical cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Reproducibility of Results; Uterine Cervical Neoplasms | 2014 |
Simultaneous positron emission tomography/magnetic resonance imaging for whole-body staging in patients with recurrent gynecological malignancies of the pelvis: a comparison to whole-body magnetic resonance imaging alone.
Topics: Adult; Aged; Cervix Uteri; Contrast Media; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Observer Variation; Ovarian Neoplasms; Ovary; Positron-Emission Tomography; Prospective Studies; Reproducibility of Results; Uterine Cervical Neoplasms; Whole Body Imaging; Young Adult | 2014 |
18F-FDG-PET/CT is of limited value in primary staging of early stage cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Cervix Uteri; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Young Adult | 2015 |
Effect of furosemide administration before F-18 fluorodeoxyglucose positron emission tomography/computed tomography on urine radioactivity and detection of uterine cervical cancer.
Topics: Female; Fluorodeoxyglucose F18; Furosemide; Humans; Multimodal Imaging; Positron-Emission Tomography; Radioactivity; Retrospective Studies; Tomography, X-Ray Computed; Urine; Uterine Cervical Neoplasms | 2014 |
Cervix carcinoma and incidental finding of medullary thyroid carcinoma by 18F-FDG PET/CT--clinical case.
Topics: Carcinoma, Neuroendocrine; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2014 |
Role of 18F-FDG PET/CT in detecting pelvic lymph-node metastases in patients with early-stage uterine cervical cancer: comparison with MRI findings.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pelvis; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2014 |
[(18)F]FDG PET/MRI vs. PET/CT for whole-body staging in patients with recurrent malignancies of the female pelvis: initial results.
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Staging; Ovarian Neoplasms; Pelvic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Whole Body Imaging | 2015 |
Validity of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for pretreatment evaluation of patients with cervical carcinoma: a retrospective pathology-matched study.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2014 |
Mediastinal sarcoidosis mimicking lymph malignancy recurrence after anti-neoplastic therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Carcinoma; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Gastrectomy; Granuloma; Humans; Hysterectomy; Lymphatic Irradiation; Lymphatic Metastasis; Mastectomy, Segmental; Mediastinal Diseases; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Stomach Neoplasms; Tissue Distribution; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2015 |
The efficacy of preoperative positron emission tomography-computed tomography (PET-CT) for detection of lymph node metastasis in cervical and endometrial cancer: clinical and pathological factors influencing it.
Topics: Adult; Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2015 |
Detection of occult primary tumors in patients with cervical metastases of unknown primary tumors: comparison of (18)F FDG PET/CT with contrast-enhanced CT or CT/MR imaging-prospective study.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2015 |
Clinical impact of FDG PET-CT on the management of patients with locally advanced cervical carcinoma.
Topics: Adult; Aged; Cervix Uteri; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Young Adult | 2014 |
[(18)F]FDG-PET standard uptake value as a metabolic predictor of bone marrow response to radiation: impact on acute and late hematological toxicity in cervical cancer patients treated with chemoradiation therapy.
Topics: Acute Disease; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Blood Cell Count; Bone Marrow; Bone Marrow Cells; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Regression Analysis; Retrospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2014 |
Prognostic value of 18F-fluorodeoxyglucose uptake in pelvic lymph nodes in patients with cervical cancer treated with definitive chemoradiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Middle Aged; Multimodal Imaging; Pelvis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2015 |
The prognostic significance of pretreatment [18F]FDG-PET/CT imaging in patients with uterine cervical cancer: preliminary results.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden; Uterine Cervical Neoplasms | 2015 |
Extensive Tattoos Mimicking Lymphatic Metastasis on Positron Emission Tomography Scan in a Patient With Cervical Cancer.
Topics: Adult; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tattooing; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2015 |
Repeated episodes of spontaneous regression/progression of cervical adenocarcinoma after adjuvant chemoradiation therapy: a case report.
Topics: Adenocarcinoma; Chemoradiotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Mediastinal Neoplasms; Middle Aged; Neoplasm Regression, Spontaneous; Positron-Emission Tomography; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2015 |
A Segmentation Algorithm for Quantitative Analysis of Heterogeneous Tumors of the Cervix With ¹⁸F-FDG PET/CT.
Topics: Algorithms; Cervix Uteri; Female; Fluorodeoxyglucose F18; Fuzzy Logic; Humans; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2015 |
Staging of cervical cancer based on tumor heterogeneity characterized by texture features on (18)F-FDG PET images.
Topics: Area Under Curve; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Support Vector Machine; Tissue Distribution; Tumor Burden; Uterine Cervical Neoplasms | 2015 |
Dose painting by numbers in a standard treatment planning system using inverted dose prescription maps.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prescriptions; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Tongue Neoplasms; Uterine Cervical Neoplasms | 2015 |
18F-FDG PET/CT of Primary Cervical Granulocytic Sarcoma.
Topics: Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma, Myeloid; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2015 |
Impact of radiation dose and standardized uptake value of (18)FDG PET on nodal control in locally advanced cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Aorta; Brachytherapy; Carcinoma, Squamous Cell; Cisplatin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed; Treatment Failure; Uterine Cervical Neoplasms; Young Adult | 2015 |
Complementary Prognostic Value of Pelvic Magnetic Resonance Imaging and Whole-Body Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Pretreatment Assessment of Patients With Cervical Cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Staging; Pelvis; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Whole Body Imaging; Young Adult | 2015 |
(18)F-FDG PET in small-cell cervical cancer: a prospective study with long-term follow-up.
Topics: Adult; Aged; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2016 |
Simultaneous [18F]FDG-PET/MRI: Correlation of Apparent Diffusion Coefficient (ADC) and Standardized Uptake Value (SUV) in Primary and Recurrent Cervical Cancer.
Topics: Adult; Aged; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2015 |
[(18)F]Fluoro-2-deoxy-2-d-glucose versus 3'-deoxy-3'-[(18)F]fluorothymidine for defining hematopoietically active pelvic bone marrow in gynecologic patients.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Bone Marrow; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Organ Sparing Treatments; Pelvic Bones; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2016 |
Weighted quantification of ¹⁸F-FDG tumor metabolism activity using fuzzy-thresholding to predict post-treatment tumor recurrence.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Area Under Curve; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; ROC Curve; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2015 |
A study of the synergistic effect of folate-decorated polymeric micelles incorporating Hydroxycamptothecin with radiotherapy on xenografted human cervical carcinoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Chemoradiotherapy; Drug Delivery Systems; Female; Fluorodeoxyglucose F18; Folic Acid; G2 Phase Cell Cycle Checkpoints; HeLa Cells; Histones; Humans; Mice, Inbred BALB C; Mice, Nude; Micelles; Microscopy, Electron, Transmission; Phosphorylation; Polyesters; Polyethylene Glycols; Polymers; Positron-Emission Tomography; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2016 |
Measuring tumor metabolic heterogeneity on positron emission tomography: utility in cervical cancer.
Topics: Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2016 |
Prognostic value of preoperative intratumoral FDG uptake heterogeneity in early stage uterine cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden; Uterine Cervical Neoplasms | 2016 |
Surgical Scar Site Recurrence in Patients With Cervical Cancer on 18F-FDG PET-CT: A Case-Control Study.
Topics: Adult; Aged; Carcinoma; Case-Control Studies; Cicatrix; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Uterine Cervical Neoplasms | 2016 |
Accuracy of PET/MR image coregistration of cervical lesions.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Uterine Cervical Neoplasms; Whole Body Imaging | 2016 |
The Volume-metabolic Combined Parameters from (18)F-FDG PET/CT May Help Predict the Outcomes of Cervical Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Uterine Cervical Neoplasms; Whole Body Imaging; Young Adult | 2016 |
Prognostic value of diffusion-weighted magnetic resonance imaging and
Topics: Adult; Aged; Chemoradiotherapy; Diffusion Magnetic Resonance Imaging; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Uterine Cervical Neoplasms | 2016 |
Patterns of failure after use of (18)F-FDG PET/CT in integration of extended-field chemo-IMRT and 3D-brachytherapy plannings for advanced cervical cancers with extensive lymph node metastases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiotherapy, Intensity-Modulated; Retrospective Studies; Tomography, X-Ray Computed; Treatment Failure; Treatment Outcome; Uterine Cervical Neoplasms | 2016 |
Prognostic Value of the Sum of Metabolic Tumor Volume of Primary Tumor and Lymph Nodes Using 18F-FDG PET/CT in Patients With Cervical Cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Aorta; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Pelvis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden; Uterine Cervical Neoplasms | 2016 |
Different Prognostic Implications of 18F-FDG PET Between Histological Subtypes in Patients With Cervical Cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Survival Analysis; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2016 |
Short-course PET based simultaneous integrated boost for locally advanced cervical cancer.
Topics: Adult; Aged; Computer Simulation; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Organs at Risk; Photons; Positron-Emission Tomography; Proton Therapy; Radiotherapy; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 2016 |
[(18)F]FDG-PET/CT metabolic parameters as useful prognostic factors in cervical cancer patients treated with chemo-radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Kaplan-Meier Estimate; Middle Aged; Multimodal Imaging; Multivariate Analysis; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2016 |
Use of Metabolic Parameters as Prognostic Factors During Concomitant Chemoradiotherapy for Locally Advanced Cervical Cancer.
Topics: Adult; Aged; Antineoplastic Agents; Area Under Curve; Brachytherapy; Carcinoma; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Survival Rate; Uterine Cervical Neoplasms | 2017 |
Comparison of retrospective PET and MRI-DWI (PET/MRI-DWI) image fusion with PET/CT and MRI-DWI in detection of cervical and endometrial cancer lymph node metastases.
Topics: Adult; Aged; Contrast Media; Diffusion Magnetic Resonance Imaging; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Uterine Cervical Neoplasms | 2016 |
Prognostic value of total lesion glycolysis measured by 18F-FDG PET/CT in patients with locally advanced cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Longitudinal Studies; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Treatment Outcome; Uterine Cervical Neoplasms | 2016 |
(18)F-FDG PET/CT can correct the clinical stages and predict pathological parameters before operation in cervical cancer.
Topics: Adult; Aged; Cervix Uteri; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tumor Burden; Uterine Cervical Neoplasms | 2016 |
Multiparametric [18F]Fluorodeoxyglucose/ [18F]Fluoromisonidazole Positron Emission Tomography/ Magnetic Resonance Imaging of Locally Advanced Cervical Cancer for the Non-Invasive Detection of Tumor Heterogeneity: A Pilot Study.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Misonidazole; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Tumor Burden; Uterine Cervical Neoplasms | 2016 |
PET/CT Response Criteria (European Organization for Research and Treatment of Cancer) Predict Survival Better Than Response Evaluation Criteria in Solid Tumors in Locally Advanced Cervical Cancer Treated With Chemoradiation.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Combined Modality Therapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Regression Analysis; Response Evaluation Criteria in Solid Tumors; Uterine Cervical Neoplasms | 2016 |
Uterine Cervical Metastasis From Primary Rectal Adenocarcinoma on PET/CT and MRI.
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rectal Neoplasms; Uterine Cervical Neoplasms | 2016 |
Maximum Standardized Uptake Value of Pelvic Lymph Nodes in [18F]-Fluorodeoxyglucose Positron Emission Tomography Is a Prognostic Factor for Para-Aortic Lymph Node Recurrence in Pelvic Node-Positive Cervical Cancer Treated With Definitive Chemoradiotherapy
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Republic of Korea; Retrospective Studies; Uterine Cervical Neoplasms | 2016 |
Pre- and per-treatment 18F-FDG PET/CT parameters to predict recurrence and survival in cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Tumor Burden; Uterine Cervical Neoplasms | 2016 |
Efficacy of qualitative response assessment interpretation criteria at 18F-FDG PET-CT for predicting outcome in locally advanced cervical carcinoma treated with chemoradiotherapy.
Topics: Adult; Aged; Carcinoma; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2017 |
Clitoral Metastasis From Advanced Cervical Carcinoma on 18F-FDG-PET/CT.
Topics: Carcinoma; Clitoris; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms; Vulvar Neoplasms | 2017 |
Unsuspected axillary lymph node metastasis of nasopharyngeal and cervical cancer on 18FDG PET/CT: a case report.
Topics: Axilla; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms; Whole Body Imaging | 2016 |
Effect of different segmentation algorithms on metabolic tumor volume measured on 18F-FDG PET/CT of cervical primary squamous cell carcinoma.
Topics: Adult; Aged; Algorithms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Middle Aged; Positron Emission Tomography Computed Tomography; Tumor Burden; Uterine Cervical Neoplasms | 2017 |
In vivo synergistic anti-tumor effect of paclitaxel nanoparticles combined with radiotherapy on human cervical carcinoma.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Cell Proliferation; Chemoradiotherapy; Drug Carriers; Drug Compounding; Female; Fluorodeoxyglucose F18; HeLa Cells; Humans; Immunohistochemistry; Ki-67 Antigen; Mice, Inbred BALB C; Mice, Nude; Nanomedicine; Nanoparticles; Paclitaxel; Platelet Endothelial Cell Adhesion Molecule-1; Polyesters; Polyethylene Glycols; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Technology, Pharmaceutical; Time Factors; Uterine Cervical Neoplasms; Vascular Endothelial Growth Factor A; X-Ray Microtomography; Xenograft Model Antitumor Assays | 2017 |
PET trumps surgical staging in locally advanced cervical cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Laparoscopy; Lymph Node Excision; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Uterine Cervical Neoplasms | 2017 |
Prognostic Significance of the Standardized Uptake Value of Pretherapeutic 18F-Labeled 2-Fluoro-2-Deoxyglucose Positron Emission Tomography/Computed Tomography in Patients With Locally Advanced Cervical Cancer.
Topics: Adult; Aged; Brachytherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms | 2017 |
18-F-fluorodeoxyglucose-positron emission tomography evaluation of early metabolic response during radiation therapy for cervical cancer.
Topics: Adult; Aged; Brachytherapy; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Metabolism; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Radioisotopes; Regression Analysis; Uterine Cervical Neoplasms | 2008 |
Mucoid impaction secondary to mucin-producing metastatic adenocarcinoma of the cervix.
Topics: Adenocarcinoma, Mucinous; Bronchial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2008 |
The impact of PET with 18FDG in radiotherapy treatment planning and in the prediction in patients with cervix carcinoma: results of pilot study.
Topics: Adult; Aged; Brachytherapy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Patient Care Planning; Pilot Projects; Positron-Emission Tomography; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2008 |
Role of PET/CT in the evaluation of cervical cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Uterine Cervical Neoplasms | 2008 |
Cervical cancer coexisting with small lymphocytic lymphoma detected during positron emission tomography/computed tomography simulation: a case report.
Topics: Biopsy; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Whole Body Imaging | 2008 |
Correlation of apparent diffusion coefficients measured by 3T diffusion-weighted MRI and SUV from FDG PET/CT in primary cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Diffusion; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2009 |
Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Registries; Uterine Cervical Neoplasms | 2009 |
Clarifying the diagnosis of clinically suspected recurrence of cervical cancer: impact of 18F-FDG PET.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Survival Rate; Uterine Cervical Neoplasms | 2008 |
Impact of manual and automated interpretation of fused PET/CT data on esophageal target definitions in radiation planning.
Topics: Automation; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Retrospective Studies; Thoracic Neoplasms; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2008 |
Unusual 2-[18F]-fluoro-2-deoxy-D-glucose accumulation induced by postoperative intestinocutaneous fistula in the patient with uterine cervical cancer and SLE.
Topics: Colostomy; Cutaneous Fistula; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Intestinal Fistula; Lupus Erythematosus, Systemic; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Complications; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2009 |
Preoperative Y-90 microsphere selective internal radiation treatment for tumor downsizing and future liver remnant recruitment: a novel approach to improving the safety of major hepatic resections.
Topics: Carcinoma, Squamous Cell; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Middle Aged; Portal Vein; Positron-Emission Tomography; Preoperative Care; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Yttrium Radioisotopes | 2009 |
18 Fluoro-2deoxy-d-glucose-positron emission tomography and locally advanced cervical cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2009 |
FDG PET/CT delayed diuretic imaging technique for differentiating invasive pelvic cancer.
Topics: Aged; Diagnostic Imaging; Diuretics; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Medical Oncology; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2009 |
The identification of a tumor of the cervix on PET/CT with bladder filling and emptying.
Topics: Carcinoma, Squamous Cell; Diuresis; Diuretics; Female; Fluorodeoxyglucose F18; Furosemide; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder; Uterine Cervical Neoplasms; Whole Body Imaging | 2009 |
Dual primary subclavicular angiosarcoma and lung cancer imaging with C-11 acetate PET and FDG PET.
Topics: Acetates; Adenocarcinoma; Aged; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Lung Neoplasms; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2009 |
Additional value of MR/PET fusion compared with PET/CT in the detection of lymph node metastases in cervical cancer patients.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms | 2009 |
Cervical cancer histology and tumor differentiation affect 18F-fluorodeoxyglucose uptake.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cell Differentiation; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Uterine Cervical Neoplasms | 2009 |
Efficacy of 18F-FDG PET/CT in the evaluation of patients with recurrent cervical carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; International Agencies; Middle Aged; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2009 |
The prognostic significance of the SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) of the cervical tumor in PET imaging for early cervical cancer: preliminary results.
Topics: Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Adjuvant; Risk Factors; Uterine Cervical Neoplasms | 2009 |
[Application of 18F-FDG PET/CT in cervical cancer with elevated levels of serum squamous cell carcinoma antigen during the follow-up].
Topics: Adult; Aged; Antigens, Neoplasm; Biomarkers, Tumor; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Serpins; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2009 |
A prospective trial comparing lymphangiogram, cross-sectional imaging, and positron emission tomography scan in the detection of lymph node metastasis in locally advanced cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Lymphography; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2010 |
Detection of hematogenous bone metastasis in cervical cancer: 18F-fluorodeoxyglucose-positron emission tomography versus computed tomography and magnetic resonance imaging.
Topics: Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplastic Cells, Circulating; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2009 |
Postoperative abdominal aspergilloma mimicking cervical cancer recurrence and diagnostic imaging, including F-fluorodeoxyglucose positron emission tomography, with false-positive findings.
Topics: Abdomen; Adult; Antigens, Neoplasm; Aspergillosis; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Complications; Radiopharmaceuticals; Serpins; Uterine Cervical Neoplasms | 2009 |
Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose-positron emission tomography simulation in patients with locally advanced cervical cancer.
Topics: Brachytherapy; Combined Modality Therapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2010 |
18F-fluorodeoxyglucose-positron emission tomography and pathologic tumor size in early-stage invasive cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2009 |
Polyostotic fibrous dysplasia mimicking bone metastases in a patient with advanced-stage cervical cancer.
Topics: Adult; Bone Neoplasms; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fibrous Dysplasia, Polyostotic; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2010 |
(18)F-FDG PET in stage IB/IIB cervical adenocarcinoma/adenosquamous carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Area Under Curve; Carcinoma, Adenosquamous; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Kaplan-Meier Estimate; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Invasiveness; Prognosis; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tumor Burden; Uterine Cervical Neoplasms | 2010 |
Pelvic lymph node F-18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Pelvis; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Recurrence; Treatment Outcome; Uterine Cervical Neoplasms | 2010 |
Diagnostic performance of fluorodeoxyglucose positron emission tomography/magnetic resonance imaging fusion images of gynecological malignant tumors: comparison with positron emission tomography/computed tomography.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Hysterosalpingography; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Observer Variation; Ovarian Neoplasms; Ovary; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Uterus | 2010 |
FDG PET-CT in cervical cancer: relationship between primary tumor FDG uptake and metastatic potential.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2010 |
Clinical and survival impact of FDG PET in patients with suspicion of recurrent cervical carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2010 |
Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis.
Topics: Chemotherapy, Adjuvant; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Gynecologic Surgical Procedures; Humans; Kaplan-Meier Estimate; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Adjuvant; Recurrence; Registries; Risk Assessment; Time Factors; Treatment Outcome; Uterine Cervical Neoplasms | 2010 |
Preoperative [18F]FDG PET/CT maximum standardized uptake value predicts recurrence of uterine cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Preoperative Period; Prognosis; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Young Adult | 2010 |
[Prognostic value of pretherapeutic 18F-FDG PET/CT in cancer of the uterine cervix: a retrospective study of 53 patients].
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms | 2010 |
Correlation between [18f]fluorodeoxyglucose positron-emission tomography scan and histology of pelvic nodes in early-stage cervical cancer.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2010 |
Vaginal gauze packing mimicking malignancy in a patient with uterine cervical cancer: a pitfall of F-18 FDG PET/CT.
Topics: Artifacts; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Surgical Sponges; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Vagina | 2010 |
Pelvic lymph node status assessed by 18F-fluorodeoxyglucose positron emission tomography predicts low-risk group for distant recurrence in locally advanced cervical cancer: a prospective study.
Topics: Adult; Aged; Antigens, Neoplasm; Biomarkers, Tumor; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Pelvis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Risk; Sensitivity and Specificity; Serpins; Uterine Cervical Neoplasms; Young Adult | 2011 |
Unusual lower limb skeletal metastases from carcinoma of the cervix: detection by F-18 FDG PET/CT.
Topics: Adult; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Leg; Positron-Emission Tomography; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2010 |
The predictive value of measurement of SUVmax and SCC-antigen in patients with pretreatment of primary squamous cell carcinoma of cervix.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Serpins; Survival Rate; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2010 |
When and how often should PET scans be performed in the management of cervical cancer?
Topics: Antineoplastic Agents; Biomarkers, Tumor; Cost-Benefit Analysis; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Salvage Therapy; Time Factors; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2010 |
Value of PET-CT in avoiding multimodality therapy in operable cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Chemotherapy, Adjuvant; Chi-Square Distribution; Cohort Studies; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Immunohistochemistry; Lymph Nodes; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiotherapy, Adjuvant; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2010 |
PET/CT evaluation of cervical cancer: spectrum of disease.
Topics: Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Internationality; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2010 |
Colovesical fistula in a patient with recurrent cervical cancer detected by FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Intestinal Fistula; Middle Aged; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2010 |
Prognostic utility of squamous cell carcinoma antigen in carcinoma of the cervix: association with pre- and posttreatment FDG-PET.
Topics: Adult; Aged; Antigens, Neoplasm; Biomarkers, Tumor; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Serpins; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2011 |
Interesting image. F-18 FDG PET images of uterine cervical cancer producing granulocyte colony stimulating factor.
Topics: Adult; Female; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Humans; Positron-Emission Tomography; Uterine Cervical Neoplasms | 2010 |
Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Young Adult | 2011 |
Split-field helical tomotherapy with or without chemotherapy for definitive treatment of cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Anatomic Landmarks; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Feasibility Studies; Female; Femur Head; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Intestines; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pelvic Bones; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Rectum; Tomography, Spiral Computed; Tomography, X-Ray Computed; Treatment Outcome; Urinary Bladder; Uterine Cervical Neoplasms | 2012 |
Accuracy of 18-fluoro-2-deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Child; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms; Young Adult | 2011 |
Impact of post-therapy positron emission tomography on prognostic stratification and surveillance after chemoradiotherapy for cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Positron-Emission Tomography; Prognosis; Recurrence; Survival Analysis; Uterine Cervical Neoplasms | 2011 |
[The accuracy of FDG-PET/CT in early-stage cervical and vaginal cancers].
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Lymph Node Excision; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Uterine Cervical Neoplasms; Vaginal Neoplasms; Young Adult | 2011 |
Metabolic response of pelvic and para-aortic lymph nodes during radiotherapy for carcinoma of the uterine cervix: using positron emission tomography/computed tomography.
Topics: Aorta; Brachytherapy; Carcinoma, Squamous Cell; Cervix Uteri; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Pelvis; Positron-Emission Tomography; Prognosis; Tomography, Emission-Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2011 |
Intramuscular metastasis of uterine cervix cancer on F-18 FDG PET/CT.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Muscle Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2011 |
Change in T2-fat saturation MRI correlates with outcome in cervical cancer patients.
Topics: Adult; Aged; Brachytherapy; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome; Tumor Burden; Uterine Cervical Neoplasms | 2011 |
Current measures of metabolic heterogeneity within cervical cancer do not predict disease outcome.
Topics: Cervix Uteri; Contrast Media; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Humans; Models, Theoretical; Neoplasm Metastasis; Positron-Emission Tomography; Predictive Value of Tests; Reproducibility of Results; Treatment Outcome; Uterine Cervical Neoplasms | 2011 |
Inhibition of tumor lactate oxidation: consequences for the tumor microenvironment.
Topics: Animals; Autoradiography; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; Cinnamates; Female; Fluorodeoxyglucose F18; Glucose; Glycolysis; Head and Neck Neoplasms; Immunoenzyme Techniques; Lactates; Linear Models; Luminescent Measurements; Mice; Mice, Nude; Monocarboxylic Acid Transporters; Nitroimidazoles; Oxidation-Reduction; Symporters; Tumor Microenvironment; Uterine Cervical Neoplasms | 2011 |
18F-fluoro-2-deoxy-D-glucose positron emission tomography standard uptake value ratio as an indicator of cervical cancer chemoradiation therapeutic response.
Topics: Adenocarcinoma; Adult; Aged; Brachytherapy; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms | 2011 |
Identification of prognostic factors in patients with cervical cancer and supraclavicular lymph node recurrence.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Prognosis; Recurrence; Survival Rate; Uterine Cervical Neoplasms | 2011 |
Preoperative staging of cervical cancer: is 18-FDG-PET/CT really effective in patients with early stage disease?
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2011 |
Metabolic response on post-therapy FDG-PET predicts patterns of failure after radiotherapy for cervical cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cervix Uteri; Cisplatin; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Treatment Failure; Uterine Cervical Neoplasms; Uterus; Young Adult | 2012 |
The SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) and serum squamous cell carcinoma antigen (SCC-ag) function as prognostic biomarkers in patients with primary cervical cancer.
Topics: Adult; Aged; Antigens, Neoplasm; Biomarkers, Tumor; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Serpins; Survival Rate; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Young Adult | 2012 |
[((18)F)-fluorodeoxyglucose PET/CT in cervix cancer: lymph node assessment and prognostic/predictive value of primary tumour analysis].
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2011 |
Lymph node assessment with (18)F-FDG-PET and MRI in uterine cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pelvis; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2011 |
Neurolymphomatosis: role of positron emission tomography in diagnosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Recurrence; Uterine Cervical Neoplasms | 2012 |
Value of magnetic resonance and ¹⁸FDG PET-CT in predicting tumor response and resectability of primary locally advanced cervical cancer after treatment with intensity-modulated arc therapy: a prospective pathology-matched study.
Topics: Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2012 |
Correlation between radiation dose to ¹⁸F-FDG-PET defined active bone marrow subregions and acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy.
Topics: Adenocarcinoma; Antineoplastic Agents; Bone Marrow; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Hematologic Diseases; Humans; Leukocyte Count; Linear Models; Middle Aged; Neutrophils; Platelet Count; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2012 |
[Laparoscopic para-aortic lymphadenectomy in advanced cervical cancer: morbidity and impact on therapy].
Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Laparoscopy; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2012 |
[Outcome of cervical carcinoma with locoregional lymph node involvement by FDG-PET].
Topics: Adult; Aged; Combined Modality Therapy; Confidence Intervals; Disease-Free Survival; Female; Fluorodeoxyglucose F18; France; Humans; Lumbosacral Region; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Uterine Cervical Neoplasms | 2012 |
Correlation between FDG uptake by PET/CT and the expressions of glucose transporter type 1 and hexokinase II in cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose Transporter Type 1; Hexokinase; Humans; Immunoenzyme Techniques; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2012 |
18F-fluorodeoxyglucose positron emisson tomography/computed tomography guided conformal brachytherapy for cervical cancer.
Topics: Brachytherapy; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Organs at Risk; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Tumor Burden; Uterine Cervical Neoplasms | 2012 |
Changes in cervical cancer FDG uptake during chemoradiation and association with response.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Brachytherapy; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiation-Sensitizing Agents; Radiopharmaceuticals; Radiotherapy Dosage; Remission Induction; Tomography, X-Ray Computed; Tumor Burden; Uterine Cervical Neoplasms | 2013 |
18-fluoro-deoxy-glucose positron emission tomography with computed tomography-based gross tumor volume estimation and validation with magnetic resonance imaging for locally advanced cervical cancers.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2012 |
Prospective study of functional bone marrow-sparing intensity modulated radiation therapy with concurrent chemotherapy for pelvic malignancies.
Topics: Adipose Tissue; Adult; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Bone Marrow; Chemoradiotherapy; Cisplatin; Feasibility Studies; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mitomycin; Multimodal Imaging; Organ Sparing Treatments; Pelvis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed; Tumor Burden; Uterine Cervical Neoplasms | 2013 |
A prospective comparison of 18F-FDG PET/CT and CT as diagnostic tools to identify the primary tumor site in patients with extracervical carcinoma of unknown primary site.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2012 |
FDG-PET-based prognostic nomograms for locally advanced cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Nomograms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms; Young Adult | 2012 |
Anatomic location of PET-positive aortocaval nodes in patients with locally advanced cervical cancer: implications for surgical staging.
Topics: Adenocarcinoma; Adult; Aged; Aorta, Abdominal; Carcinoma, Squamous Cell; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Middle Aged; Neoplasm Grading; Neoplasm Staging; Pelvis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2012 |
Prognostic significance of volume-based metabolic parameters in uterine cervical cancer determined using 18F-fluorodeoxyglucose positron emission tomography.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms; Young Adult | 2012 |
Metabolic response of lymph nodes immediately after RT is related with survival outcome of patients with pelvic node-positive cervical cancer using consecutive [18F]fluorodeoxyglucose-positron emission tomography/computed tomography.
Topics: Adult; Aged; Brachytherapy; Cervix Uteri; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Irradiation; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Pelvis; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2012 |
Clinical impact of ¹⁸F-FDG PET/CT in the pretreatment evaluation of patients with locally advanced cervical carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2012 |
Vesicovaginorectal fistula on a FDG PET/CT of a patient with recurrent cervical cancer and end-stage renal disease.
Topics: Female; Fluorodeoxyglucose F18; Humans; Kidney Failure, Chronic; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Rectal Fistula; Recurrence; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Vaginal Fistula | 2012 |
Hypoxia imaging of uterine cervix carcinoma with (18)F-FETNIM PET/CT.
Topics: Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Hypoxia; Imaging, Three-Dimensional; Middle Aged; Multimodal Imaging; Nitroimidazoles; Positron-Emission Tomography; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2012 |
Tumor volume and subvolume concordance between FDG-PET/CT and diffusion-weighted MRI for squamous cell carcinoma of the cervix.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden; Uterine Cervical Neoplasms | 2013 |
Subcutaneous and intramuscular metastases of cervix cancer detected with ¹⁸F-fluoro-2-deoxyglucose positron emission tomography/computed tomography after the chemoradiation therapy.
Topics: Carcinoma; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Muscle Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms; Subcutaneous Tissue; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2013 |
Anatomic distribution of fluorodeoxyglucose-avid para-aortic lymph nodes in patients with cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Aorta; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Conformal; Retrospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Vena Cava, Inferior | 2013 |
Temporal analysis of intratumoral metabolic heterogeneity characterized by textural features in cervical cancer.
Topics: Adult; Aged; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Time Factors; Treatment Outcome; Uterine Cervical Neoplasms | 2013 |
Physiologic FDG-PET three-dimensional brachytherapy treatment planning for cervical cancer.
Topics: Brachytherapy; Female; Fluorodeoxyglucose F18; Humans; Prospective Studies; Radiotherapy Planning, Computer-Assisted; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2002 |
Contribution of whole-body 18FDG PET imaging in the management of cervical cancer.
Topics: Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Retrospective Studies; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2002 |
A combined PET/CT scanner: the path to true image fusion.
Topics: Aged; Colonography, Computed Tomographic; Colorectal Neoplasms; Equipment Design; Female; Fluorodeoxyglucose F18; Forecasting; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Radiopharmaceuticals; Tomography Scanners, X-Ray Computed; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2002 |
Improved prognostic value of 18F-FDG PET using a simple visual analysis of tumor characteristics in patients with cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Observer Variation; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Single-Blind Method; Survival Analysis; Tomography, Emission-Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2003 |
Posttherapy surveillance monitoring of cervical cancer by FDG-PET.
Topics: Adenocarcinoma; Carcinoma; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multivariate Analysis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2003 |
Detection of early recurrence with 18F-FDG PET in patients with cervical cancer.
Topics: Adult; Aged; Carcinoma; Carcinoma, Squamous Cell; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2003 |
Evaluation of 18F-FDG PET with bladder irrigation in patients with uterine and ovarian tumors.
Topics: Adult; Aged; Aged, 80 and over; Artifacts; Carcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Radiopharmaceuticals; Therapeutic Irrigation; Tomography, Emission-Computed; Urinary Bladder; Uterine Cervical Neoplasms; Uterine Neoplasms | 2003 |
Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cell Hypoxia; Combined Modality Therapy; Coordination Complexes; Copper Radioisotopes; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Life Tables; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Organometallic Compounds; Prospective Studies; Radiation Tolerance; Radiopharmaceuticals; Survival Rate; Thiosemicarbazones; Tomography, Emission-Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2003 |
FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma.
Topics: Adult; Aged; Brachytherapy; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Radiotherapy; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2003 |
The role of PET scanning in the detection of recurrent cervical cancer.
Topics: Adult; Aged; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2003 |
Value of dual-phase 2-fluoro-2-deoxy-d-glucose positron emission tomography in cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2003 |
Delayed (18)F-FDG PET for detection of paraaortic lymph node metastases in cervical cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Prospective Studies; Time Factors; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2003 |
Restaging of recurrent cervical carcinoma with dual-phase [18F]fluoro-2-deoxy-D-glucose positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Confidence Intervals; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Probability; Prospective Studies; Risk Assessment; Salvage Therapy; Sensitivity and Specificity; Survival Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2004 |
Treatment planning guidelines regarding the use of CT/PET-guided IMRT for cervical carcinoma with positive paraaortic lymph nodes.
Topics: Female; Fluorodeoxyglucose F18; Humans; Intestine, Small; Kidney; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2004 |
Preliminary report of using FDG-PET to detect extrapelvic lesions in cervical cancer patients with enlarged pelvic lymph nodes on MRI/CT.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Pelvis; Prospective Studies; Radiopharmaceuticals; Statistics as Topic; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2004 |
Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome.
Topics: Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk; Survival Analysis; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2004 |
Accurate diagnosis of regional metastasis from cervical cancer: is PET the answer?
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2004 |
Lymph node control in cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2004 |
Detection of recurrent cervical cancer by whole-body FDG PET scan in asymptomatic and symptomatic women.
Topics: Adult; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Cervical Neoplasms; Whole-Body Counting | 2004 |
18F-FDG PET imaging in posttherapy monitoring of cervical cancers: from diagnosis to prognosis.
Topics: Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome; Uterine Cervical Neoplasms | 2004 |
Metabolic monitoring of advanced uterine cervical cancer neoadjuvant chemotherapy by using [F-18]-Fluorodeoxyglucose positron emission tomography: preliminary results in three patients.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2004 |
Peritoneal carcinomatosis from cervical cancer detected by F-18 FDG positron emission tomography.
Topics: Adult; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2005 |
Lack of benefit of concurrent chemotherapy in patients with cervical cancer and negative lymph nodes by FDG-PET.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Proportional Hazards Models; Prospective Studies; Radiation-Sensitizing Agents; Radiopharmaceuticals; Registries; Survival Analysis; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2005 |
Fusion images of Tl-201 SPECT and FDG PET with CT in detection of cervical carcinoma with bladder invasion.
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Urinary Bladder; Uterine Cervical Neoplasms | 2005 |
Incidental ovarian 18F-FDG accumulation on PET: correlation with the menstrual cycle.
Topics: Adult; Breast Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Spectroscopy; Menopause; Menstrual Cycle; Middle Aged; Neoplasm Metastasis; Neoplasms; Ovarian Neoplasms; Ovary; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors; Uterine Cervical Neoplasms | 2005 |
FDG-PET for management of cervical and ovarian cancer.
Topics: CA-125 Antigen; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Uterine Cervical Neoplasms | 2005 |
The usefulness of MRI and PET imaging for the detection of parametrial involvement and lymph node metastasis in patients with cervical cancer.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Uterine Cervical Neoplasms | 2005 |
Staging of advanced cervical cancer.
Topics: Antineoplastic Agents; Cisplatin; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Radiation-Sensitizing Agents; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2005 |
Metabolic monitoring of chemosensitivity with 18FDG PET.
Topics: Body Weight; Brain; Drug Screening Assays, Antitumor; Female; Fluorodeoxyglucose F18; Glucose; Humans; Linear Models; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors; Uterine Cervical Neoplasms | 2005 |
Sequential FDG-PET brachytherapy treatment planning in carcinoma of the cervix.
Topics: Adult; Aged; Brachytherapy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Rectum; Urinary Bladder; Uterine Cervical Neoplasms | 2005 |
18F-FDG uptake in an ovary containing a hemorrhagic corpus luteal cyst: false-positive PET/CT in a patient with cervical carcinoma.
Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hemorrhage; Humans; Ovarian Cysts; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2005 |
FDG-PET in the detection of recurrence of uterine cervical carcinoma following radiation therapy--tumor volume and FDG uptake value.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2006 |
F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2006 |
The role of hybrid PET/CT in the evaluation of patients with cervical cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography; Uterine Cervical Neoplasms; Whole Body Imaging | 2006 |
Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography.
Topics: Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Lymph Nodes; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms; Vaginal Neoplasms | 2005 |
FDG-PET in carcinoma of the uterine cervix with endometrial extension.
Topics: Adenocarcinoma; Carcinoma, Adenosquamous; Carcinoma, Neuroendocrine; Carcinoma, Squamous Cell; Cervix Uteri; Combined Modality Therapy; Disease-Free Survival; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Invasiveness; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Treatment Outcome; Uterine Cervical Neoplasms | 2006 |
Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2006 |
Low value of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography in primary staging of early-stage cervical cancer before radical hysterectomy.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Uterine Cervical Neoplasms | 2006 |
FDG-PET in the evaluation of cervical cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2005 |
4th International Cervical Cancer Conference: update on PET and cervical cancer.
Topics: Brachytherapy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms; Whole Body Imaging | 2005 |
FDG-PET imaging for the assessment of physiologic volume response during radiotherapy in cervix cancer.
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Brachytherapy; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Uterine Cervical Neoplasms | 2006 |
Clinical impact of FDG-PET imaging in post-therapy surveillance of uterine cervical cancer: from diagnosis to prognosis.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Palliative Care; Pelvic Exenteration; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy; Sensitivity and Specificity; Uterine Cervical Neoplasms | 2006 |
Microvessel density and p53 in detecting cervical cancer by FDG PET in cases of suspected recurrence.
Topics: Adult; Aged; Animals; Biomarkers; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Microvessels; Middle Aged; Patient Selection; Positron-Emission Tomography; Recurrence; Regression Analysis; Sensitivity and Specificity; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms | 2006 |
Comparative benefits and limitations of 18F-FDG PET and CT-MRI in documented or suspected recurrent cervical cancer.
Topics: Antigens, Neoplasm; Documentation; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Recurrence; Salvage Therapy; Sensitivity and Specificity; Serpins; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2006 |
Clinical impact of integrated PET/CT on the management of suspected cervical cancer recurrence.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2007 |
Adaptive brachytherapy treatment planning for cervical cancer using FDG-PET.
Topics: Adult; Aged; Brachytherapy; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Uterine Cervical Neoplasms | 2007 |
A case of primary unknown carcinoma with lymphatic spread.
Topics: Cystadenocarcinoma, Serous; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasms, Unknown Primary; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2006 |
Characterization of surgically transposed ovaries in integrated PET/CT scan in patients with cervical cancer.
Topics: Adult; Female; Fertility; Fluorodeoxyglucose F18; Humans; Hysterectomy; Medical Records; Neoplasm Staging; Ovary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms | 2007 |
A prospective study of the accuracy of 18Fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pelvic Exenteration; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Vaginal Neoplasms; Vulvar Neoplasms | 2007 |
Mycobacterium tuberculosis infection in patients with cancer, the role of 18-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring treatment response.
Topics: Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Immunocompromised Host; Lymphoma, Large B-Cell, Diffuse; Mediastinal Diseases; Middle Aged; Mycobacterium tuberculosis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tuberculosis, Lymph Node; Uterine Cervical Neoplasms | 2007 |
Image of the month. Diagnosis of endoneural sciatic nerve invasion by uterine cervical epidermoid cancer using [18F]FDG-PET/CT.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Invasiveness; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sciatic Neuropathy; Subtraction Technique; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2007 |
FDG-PET is useful in staging and follow-up of primary uterine cervical lymphoma.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2007 |
The role of FDG-PET/CT imaging after radiation therapy.
Topics: Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2007 |
The contribution of new imaging techniques in staging cervical cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2007 |
18F-fluoro-2-deoxy-D-glucose-positron emission tomography (PET)/PET-computed tomography in carcinoma of the cervix.
Topics: Female; Fluorodeoxyglucose F18; Humans; Preoperative Care; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2007 |
The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Preoperative Care; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2007 |
FDG-PET in cervical cancer: staging, re-staging and follow-up.
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Outcome Assessment, Health Care; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2007 |
Integrated PET/CT for the evaluation of para-aortic nodal metastasis in locally advanced cervical cancer patients with negative conventional CT findings.
Topics: Adult; Aged; Aged, 80 and over; CA-125 Antigen; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2008 |
Standardized uptake value in para-aortic lymph nodes is a significant prognostic factor in patients with primary advanced squamous cervical cancer.
Topics: Adult; Aged; Aorta; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Survival Rate; Taiwan; Uterine Cervical Neoplasms | 2008 |
Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma.
Topics: Adult; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Reproducibility of Results; Salvage Therapy; Survival Analysis; Uterine Cervical Neoplasms | 2007 |
Osteoradionecrosis after three-dimensional conformal radiotherapy for recurrent cervical cancer presenting as a progressive osteolytic lesion.
Topics: Bone Neoplasms; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Ilium; Middle Aged; Neoplasm Recurrence, Local; Osteolysis; Osteoradionecrosis; Positron-Emission Tomography; Radiotherapy, Conformal; Salvage Therapy; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Whole Body Imaging | 2008 |
False-positive rate of posttherapy positron emission tomography in cervical cancer.
Topics: False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Failure; Uterine Cervical Neoplasms | 2008 |
Surgical versus radiographic determination of para-aortic lymph node metastases before chemoradiation for locally advanced cervical carcinoma: a Gynecologic Oncology Group Study.
Topics: Adult; Aged; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Survival Rate; Uterine Cervical Neoplasms | 2008 |
Performance of FDG-PET/CT for diagnosis of recurrent uterine cervical cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2008 |
Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Para-Aortic Bodies; Pelvic Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2008 |
Positron emission tomography in evaluating the feasibility of curative intent in cervical cancer patients with limited distant lymph node metastases.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Prospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2008 |
Performance evaluation of a large axial field-of-view PET scanner: SET-2400W.
Topics: Bone Neoplasms; Equipment Design; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Phantoms, Imaging; Scattering, Radiation; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 1997 |
Fluorine-18-fluorodeoxyglucose PET identification of cardiac metastasis arising from uterine cervical carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Squamous Cell; Combined Modality Therapy; Echocardiography; Electrocardiography; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Heart Neoplasms; Humans; Hysterectomy; Lymph Node Excision; Lymphatic Metastasis; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Time Factors; Uterine Cervical Neoplasms | 1998 |
Evaluation of FDG PET in patients with cervical cancer.
Topics: Carcinoma, Squamous Cell; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 1999 |
Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study.
Topics: Aorta; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Pelvis; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 1999 |
18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT).
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Prospective Studies; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed; Tongue Neoplasms; Uterine Cervical Neoplasms | 1999 |
The detection of unknown primary tumors in patients with cervical metastases by dual-head positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 1999 |
Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2001 |
[18F-FDG positron-emission-tomography in cervical carcinoma: preliminary findings].
Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2001 |
Positron emission tomography for the evaluation of metastases in patients with carcinoma of the cervix: a retrospective review.
Topics: Adult; Biopsy, Needle; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2001 |
Lymph node staging by positron emission tomography in patients with carcinoma of the cervix.
Topics: Actuarial Analysis; Adult; Aged; Aged, 80 and over; Carcinoma; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed; United States; Uterine Cervical Neoplasms | 2001 |
The role of whole-body FDG-PET in preoperative assessment of tumor staging in oral cancers.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Carcinoma, Verrucous; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Radiopharmaceuticals; Statistics, Nonparametric; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2001 |
Therapy monitoring using FDG-PET in metastatic cervical cancer.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2000 |
Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Analysis of Variance; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Radiopharmaceuticals; Survival Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2002 |